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Abstract
Over the past few decades, medical imaging techniques, e.g., computed tomography
(CT), positron emission tomography (PET), have been widely used to improve the
state of diagnosis, prognosis, and treatment of diseases. However, reading medical
images and making diagnosis or treatment planning require well-trained medical
specialists, which is labor-intensive, time-consuming, high-cost and error-prone.
With the emerging of deep learning, doctors and researchers have started to benefit
from medical image analysis in various applications, e.g., medical image registration,
classification, detection and segmentation. Among these tasks, segmentation is the
most common area of applying deep learning to medical imaging. How to improve
medical diagnosis by advancing the segmentation in computer-aided diagnosis systems
has become an active research topic.
In this dissertation, we will address this topic in following aspects. (i) We propose
a 3D-based coarse-to-fine framework to effectively and efficiently tackle the challenges
of limited amount of annotated 3D data and limited computational resources in the
field of volumetric medical image segmentation. (ii) We extend the 3D coarse-to-fine to
be multi-scale to early detect the small but clinically important pancreatic ductal ade-
nocarcinoma (PDAC) tumors, and provide radiologists with interpretable abnormality
locations by segmentation-for-classification. (iii) We extend the segmentation-for-
classification to screen pancreatic neuroendocrine (PNETs) tumors by incorporating
dual-phase information and dilated pancreatic duct that is regarded as the sign of high
risk for pancreatic cancer. (iv) Going further, we investigate the mainstream methodol-
ii
ogy in the segmentation area and then explore the novel idea of AutoML in the medical
imaging field to automatically search the neural network architectures tailoring for the
segmentation task, which further advances the medical image segmentation field. (v)
Moving forward beyond pancreatic tumors, we are the first to address the clinically
critical task of detecting, identifying and characterizing suspicious cancer metastasized
lymph nodes (LNs) by proposing a 3D distance stratification strategy to simulate and
simplify the high-level reasoning protocols conducted by radiation oncologists in a
divide-and-conquer manner. (vi) The 3D distance stratification strategy is upgraded
by our proposed multi-branch detection-by-segmentation, which further advances the
finding, identifying and segmenting of metastasis-suspicious LNs.
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Chapter 1
Introduction
Over the past few decades, medical imaging techniques, e.g., magnetic resonance
imaging (MRI), computed tomography (CT), positron emission tomography (PET),
ultrasound, and X-ray, have been widely used to improve the state of medical diagnosis,
prognosis and treatment. However, reading medical images and making diagnosis or
treatment planning require well-trained medical specialists. Given the wide variation in
medical imaging and potential fatigue of human experts, these tasks are labor-intensive,
time-consuming, high-cost and error-prone.
Deep learning has a game-changing potential to improve the state of preventative
and precision medicine within medical image computing. In medical imaging, preven-
tative medicine refers to early detection of disease findings, e.g., colonic polyps [1],
lung nodules or liver/bone lesions [2], with the goal of timely patient intervention
and management [3]. It is traditionally done by medical experts through manual
examination on non-invasive imaging modalities, but more recently computer-aided
diagnosis systems are coming into prominence. Within imaging, the precision medicine
stands for quantitatively and precisely computing imaging biomarkers, e.g., volumetric
tumor measurements for tracking and beyond, to improve clinical decision making and
patient outcomes [3]. Current radiological practices are still largely qualitative, but
automated quantitative assessment shows a significantly better surrogate endpoint
than human assessment for predicting overall survival [4]. Therefore, advanced au-
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tomatic computer-aided diagnosis solutions could ultimately serve as a blueprint to
improve the overall survival.
Extracting effective features for medical image analysis problems is notoriously
hard for hand-crafted designs whereas deep learning is the state-of-the-art technique
for automatically learning features in a data-driven perspective and achieves this
goal. With the emerging of deep learning, doctors and researchers have started
to benefit from medical image analysis in various applications, e.g., medical image
registration [5][6], classification [7][8], detection [2][9], segmentation [10][11] and other
tasks [12][13]. Among these tasks, segmentation is the most common area of applying
deep learning to medical imaging [14].
In medical image, segmentation is the process of partitioning an image into different
segments, with these segments corresponding to different tissues, organs, lesions,
pathologies, or other biologically relevant structures. Medical image segmentation is
made difficult by low contrast, high variations, inevitable noise, and other imaging
ambiguities, e.g., missing edges, indistinguishable textures, region of interest (ROI)
messed into clustered backgrounds. Although challenging, it is a prerequisite step for
many clinical applications, such as diabetes inspection [15], cancer diagnosis [16], and
surgical planning [17]. Therefore, it is well worth exploring automatic segmentation
to advance the computer-aided diagnosis systems.
In this dissertation, we advance the volumetric medical image segmen-
tation via state-of-the-art deep learning techniques to improve the state
of medical diagnosis.
In one aspect, we explore how to segment organs and/or tumors more accurate, as
presented in chapters from Chapter 3 to Chapter 6. Take, for example, the pancreas
segmentation with its extension to early detection and segmentation of pancreatic
tumors as shown in Fig. 1.1, we visualize several contrast-enhanced CT cases from
online open dataset (NIH normal pancreas [18] and MSD abnormal pancreas [19]),
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Figure 1.1. Typical examples from NIH Pancreas [18] in the 1st row, MSD Pancreas
Tumors [19] in the 2nd row, and JHU PDAC pancreas [20] in the 3rd row. Two slices
of different cases are randomly chosen from each dataset. Normal Pancreas regions are
masked as blue and abnormal pancreas regions are masked as red. Best viewed in color.
and our in-house abnormal pancreas dataset (JHU PDAC [20]). 95% of all pancreatic
cancer cases are pancreatic adenocarcinoma (PDAC) [21], which is the most common
type of pancreatic cancers. In the early stage of pancreatic cancers, it often has few
symptoms and is very difficult to discover. By the time of diagnosis, the cancer has
often spread to other parts of the body, leading to a very poor prognosis (a five-year
survival rate of 5% [22]). But, for cases diagnosed early, the survival rate rises to
about 20% [23]. Hence, it is very important to study the possibility of segmenting and
detecting both normal pancreas and abnormal pancreas in common examinations, e.g.,
the abdominal CT scan. The main challenges of pancreas segmentation and the early
detection of pancreatic cancers lie in several aspects: 1) the small size of targets with
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Figure 1.2. Typical examples with varying size and appearance at scatteredly distributed
locations from the in-house GTVLN dataset [24]. The red arrow points out the location of
GTVLN with a yellow dot indicates the position. Best viewed in color.
respect to the whole volume; 2) the large variations in location, shape and appearance
across different cases; 3) the abnormalities, i.e., the pancreas tumors, can change the
texture of surrounding tissues a lot; 4) the anisotropic property along z-axis, which
make the automatic segmentation even harder.
In another aspect, we are the first to computationally address the clinically critical
task of segmenting, identifying and characterizing suspicious cancer metastasized
lymph nodes (termed as oncology-significant lymph nodes, abbreviated as OSLNs, or
lymph node gross tumor volume, abbreviated as GTVLN ) in Chapter 7 and Chapter 8.
It is an extremely challenging and time-consuming task to identify GTVLN , even for
experienced radiation oncologists. High-level sophisticated clinical reasoning guidelines
are needed, leading to the risk of uncertainty and subjectivity with high inter-observer
variabilities [25]. Refer to Fig. 1.2 as an illustration of GTVLN , the challenges of
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this task are lying in following aspects. (1) Finding GTVLN is often performed using
radiotherapy CT (RTCT) that (unlike diagnostic CT) is not contrast-enhanced. Hence
the metastasis signs for identifying GTVLN are subtle. (2) GTVLN itself has poor
contrast. Because of the shape and appearance ambiguity, it can be easily confused
with vessels or muscles. (3) The size and shape of GTVLN vary considerably with
large amounts of smaller ones that are harder to detect. As far as we know, no prior
work, as of yet, has computationally studied the GTVLN segmentation and detection
in non-contrast RTCT scans.
1.1 Challenges and Our Contributions
1.1.1 Volumetric Pancreas Segmentation
With the rapid development of deep neural networks and their success in many
computer vision tasks [26]–[28], many deep learning based methods have been proposed
for pancreas segmentation and achieved considerable progress [18], [29], [30]. However,
these methods are based on 2D fully convolutional networks (FCNs) [31], which
perform segmentation slice by slice whereas CT volumes are indeed 3D data. Using
3D deep networks for organ segmentation [10], [11], [32]–[34], is a recent trend but not
yet applied to the pancreas. An obstacle is that training 3D deep networks suffers
from the “out of memory” problem. 2D FCNs can accept a whole 2D slice as input,
but 3D FCNs cannot be fed a whole 3D volume due to the limited GPU memory size.
A common solution is to train 3D FCNs from small sub-volumes and test them in a
sliding-window manner, i.e., performing 3D segmentation on densely and uniformly
sampled sub-volumes one by one. Usually, these neighboring sampled sub-volumes
overlap with each other to improve the robustness of the final 3D results. It is worth
noting that the overlap size is a trade-off between the segmentation accuracy and
the time cost. Setting a larger/smaller overlap size generally leads to a better/worse
segmentation accuracy but takes more/less time during testing. To address this
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challenge, we propose a 3D coarse-to-fine framework to first obtain the rough
location of the target pancreas from the whole CT volume by a 3D FCN trained on
whole CT volumes, and then refine the segmentation by another 3D FCN trained on
the pancreas regions only.
To our best knowledge, we are one of the first studies to segment the challenging
normal and abnormal pancreases using 3D networks which leverage the rich spa-
tial information. The effectiveness and efficiency of the proposed 3D coarse-to-fine
framework are demonstrated on two pancreas segmentation datasets where we achieve
the state-of-the-art with relative low time cost. It is worth mentioning that, although
our focus here is pancreas segmentation, our framework is generic and can be directly
applied to segmenting other medical organs.
1.1.2 Pancreatic Tumors Segmentation for Classification
Next, we extend the aforementioned 3D coarse-to-fine framework to segment PDAC
or PNETs from a mixture of normal and abnormal CT scans. At a first glance,
we need to classify each CT scan to be normal or abnormal. This is not a simple
classification task since radiologists also want to know the location of pancreatic
tumors, we suggest a solution named segmentation-for-classification, which trains
segmentation models and uses their outputs for classification. The difficulty mainly lies
in the tiny size, irregular shape and low contrast around the boundary of pancreatic
tumors. In segmenting PDAC, to deal with tumors of various sizes, we adopt a
segmentation network with multiple input scales, i.e., 643, 323 and 163 volumes. But,
voting that small input regions lead to a high false alarm rate, we adopt a coarse-
to-fine testing strategy, which uses the 643 network for a coarse scan, and then the
323&163 networks inside the bounding box to detect small tumors that are possibly
ignored in the previous stage. A non-parameterized post-processing algorithm is
designed to remove outliers. We name this framework as multi-scale coarse-to-fine
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to do segmentation-for-classification. In segmenting PNETs, on the one hand,
to deal with the observation that some PNETs are only visible to radiologists in
either phase (venous or arterial phase), the dual-phase information is straightforwardly
combined to reduce the missing detection of PNETs. On the other hand, radiologists
are very sensitive to the dilated pancreatic duct when reading CT scans. There are
often occasions the pancreatic duct is visible to be dilated although the PNETs regions
are barely visible from CT appearance and texture. So in order to incorporate this
knowledge to our framework, we annotate dilated pancreatic duct as well and segment
them in the meantime, which is regarded as the sign of high risk for pancreatic cancer.
Our contributions in segmenting PDACs or PNETs are: 1) we voxelwisely annotate
a PDAC and PNET dataset, which are currently the largest pancreatic tumors dataset
to the best of our knowledge; 2) we adopt a segmentation-for-classification frame-
work to conduct an interpretable abnormality detection, which provides radiologists
with suspicious regions for further diagnosis; 3) our framework achieves a high sensitiv-
ity and specificity in terms of binary abnormal classification, which shows a promising
direction to make a potential significant clinical impact.
1.1.3 Neural Architecture Search for Medical Image Segmen-
tation
Going one step further, we investigate the mainstream methodology in the segmentation
area and then explore the novel idea of NAS/AutoML in medical imaging field to
develop the state-of-the-art segmentation network. The well-known fully convolutional
neural networks (FCNs) [31], e.g., 2D and 3D FCNs, deliver powerful representation
ability and good invariant properties. The 2D FCNs based methods [18], [29], [30],
[35], [36] perform the segmentation slice-by-slice from different views, then fuse 2D
segmentation output to obtain a 3D result, which is a remedy against the ignorance
of the rich spatial information. To make full use of the 3D context, 3D FCNs based
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methods [10], [11], [37], [38] directly perform the volumetric prediction. However, the
demanding computation and high GPU consumption of 3D convolutions limit the
depth of neural networks and input volume size, which impedes the massive application
of 3D convolutions. Recently, the Pseudo-3D (P3D) [39] was introduced to replace 3D
convolution k×k×k with two convolutions, i.e., k×k×1 followed by 1×1×k, which
can reduce the number of parameters and show good learning ability in [40], [41] on
anisotropic medical images. However, all the aforementioned existing works choose the
network structure empirically, which often impose explicit constraints, i.e., either 2D,
3D or P3D convolutions only, or 2D and 3D convolutions are separate from each other.
These hand-designed segmentation networks with architecture constraints might not
be the optimal solution considering either the ignorance of the rich spatial information
for 2D or suffering from the demanding computations for 3D. Drawing inspiration
from recent success of Neural Architecture Search (NAS), we take one step further
to let the segmentation network automatically choose between 2D, 3D, or P3D
convolutions at each layer by formulating the structure learning as differentiable
neural architecture search [42], [43].
To the best of our knowledge, we are one of the first to explore the idea of
NAS/AutoML in medical imaging field. Previous work [44] used reinforcement learning
and the search restricts to 2D based methods, whereas we use differentiable NAS
and search between 2D, 3D and P3D, which is more effective and efficient. Without
pretraining, our searched architecture, named V-NAS, outperforms other state-of-the-
arts on segmentation of normal pancreas, the abnormal lung tumors and pancreatic
tumors. In addition, the searched architecture on one dataset can be well generalized
to others, which shows the robustness and potential clinical use of our approach.
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1.1.4 Metastasis-Suspicious Lymph Node Detection by Seg-
mentation
Measuring lymph nodes (LNs) size and assessing its status are important clinical tasks,
usually used to monitor cancer diagnosis and treatment responses and to identify
treatment areas for radiotherapy. According to the Revised RECIST guideline [45],
[46], only enlarged LNs with a short axis more than 10-15 mm in computed tomography
(CT) images should be considered as abnormal. Such enlarged LNs have been the
only focus, so far, of LN segmentation and detection works [7], [47]–[53]. However,
in cancer treatment, besides the primary tumor, all metastasis-suspicious LNs are
required to be treated. This includes the enlarged LNs, as well as smaller ones that are
associated with a high positron emission tomography (PET) signal or any metastasis
signs in CT. This larger category is regarded as lymph node gross tumor volume,
abbreviated as GTVLN . Identifying the GTVLN and assessing their spatial relationship
and causality with the primary tumor is a key requirement for a desirable cancer
treatment outcome [54].
Identifying GTVLN can be a daunting and time-consuming task, even for expe-
rienced radiation oncologists. It requires using high-level sophisticated reasoning
protocols and faces strong uncertainty and subjectivity with high inter-observer vari-
ability [25]. To the best of our knowledge, this problem has not been previously tackled
in a fully automatized way. Our task on GTVLN detection is more challenging for
the following reasons: (1) Finding GTVLN is often performed using radiotherapy CT
(RTCT), which, unlike diagnostic CT, is not contrast-enhanced. (2) GTVLN exhibit
low contrast with surrounding tissues and can be easily confused with other anatomical
structures, e.g., vessels and muscles, due to shape and appearance ambiguity. (3) The
size and shape of GTVLN can vary considerably, and GTVLN are often scatteredly
distributed at small size in a large spatial range of anatomy locations. There is an
observation that GTVLN has higher frequencies at smaller sizes than enlarged LNs,
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challenging its detection. While, many previous works proposed automatic detection
systems for enlarged LNs in contrast-enhanced CT [2], [7], [47], [48], [51], [53], [55],
no work, as of yet, has focused on OSLN detection on non-contrast RTCT. Given
the considerable differences between enlarged LNs and GTVLN , further innovation is
required for robust and clinically useful GTVLN detection.
Our contributions can be summarized as follows: 1) To the best of our knowledge,
we are the first to address the clinically critical task of detecting, identifying and
characterizing GTVLN . 2) We propose a novel 3D distance stratification strategy
to divide and conquer the complex distribution of GTVLN into tumor-proximal
and tumor-distal sub-categories, to be solved separately, which emulates physician’s
decision process. 3) Besides RTCT, we incorporate the PET imaging modality and 3D
tumor distance maps into our detection-by-segmentation network. 4) We propose a
novel GLNet to incorporate high-level ontology-derived semantic attributes of GTVLN
with localized features computed from RTCT/PET. 5) We collect and evaluate on the
largest dataset to date on chest and abdominal radiotherapy. Our dataset comprises
of 651 voxelwise-labeled GTVLN (by board-certified radiation oncologists) of 141
esophageal cancer patients. Our system improves the detection recall compared
against the previous state-of-the-art CT-based detection method.
1.2 Dissertation Statement
Medical image segmentation is an important step in computer-aided diagnosis pipelines.
By designing advanced network backbone/architectures and/or migrating rich knowl-
edge from routine works of medical experts into automatic computer-aided diagnosis
solutions can improve medical diagnosis.
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1.3 Overview
The overview of this dissertation is illustrated as the following.
In Chapter 1 (this chapter), we introduce the topic of medical medical image segmen-
tation, including definition, justification and application. We discuss the underlying
challenges and our contributions to this dissertation topic.
In Chapter 2, we summarize previous works on the medical image analysis, especially
the prevailing segmentation task for different targets and applications.
In Chapter 3, we discuss a 3D coarse-to-fine framework to deal with the limited
amount of computational resources for the volumetric medical image segmentation.
In Chapter 4, we propose a multi-scale segmentation for classification to detect the
lethal pancreatic ductal adenocarcinoma tumors from CT images.
In Chapter 5, we extend the segmentation for classification framework to detect the
pancreatic neuroendocrine tumors from dual-phase CT images.
In Chapter 6, we propose to automatically design the network architecture tailoring
to the volumetric medical image segmentation problem.
In Chapter 7, we make an first attempt to find and identify small but critically impor-
tant objects, i.e., suspicious cancer metastasized lymph nodes, from 3D multi-modality
images via a divide-and-conquer decision stratification approach.
In Chapter 8, we build a multi-branch detection-by-segmentation network via a dis-
tance based stratification to improve the finding, identifying and segmenting of the
suspicious cancer metastasized lymph nodes from 3D multi-modality imaging.
In Chapter 9, we summarize and conclude this dissertation.
1.4 Relevant Publications
The following publications or pre-prints compose the ideas in this dissertation. The
“∗” indicates equal contribution.
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Chapter 2
Related Work
In this chapter, we discuss related works in literature in the scope of general medical
image segmentation, neural architecture search, lymph node detection and segmenta-
tion.
2.1 General Medical Image Segmentation
In the medical image segmentation field, starting from handcrafted features, there
are methods proposed to use region growing [56], intensity thresholding [57], and
deformable models [58], which however often suffer from the limited feature represen-
tation ability and are less invariant to the large organ/lesion variations. The medical
image analysis community is facing a revolution brought by the fast development of
deep networks [59], [60]. Deep Convolutional Neural Networks (CNNs) based methods
have dominated the research area of medical image segmentation in the last few years.
Generally speaking, CNN-based methods for medical image segmentation can be
divided into three major categories: 2D CNNs based, 3D CNNs based and 2D and 3D
CNNs fusion.
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2.1.1 2D CNNs for Segmentation
2D CNNs based methods [18], [29], [36] performed volumetric segmentation slice by
slice from different views, and then fused the 2D segmentation results to obtain a 3D
Volumetric Segmentation result. In the early stage, the 2D segmentation based models
were trained from image patches and tested in a patch by patch manner [18], which is
time consuming. Since the introduction of fully convolution networks (FCNs) [31],
almost all the 2D segmentation methods are built upon 2D FCNs to perform holistic
slice segmentation during both training and testing. Roth et al [29] performed Pancreas
segmentation by a holistic learning approach, which first segment pancreas regions by
holistically-nested networks [27] and then refine them by the boundary maps obtained
by robust spatial aggregation using random forest. The U-Net [36] is one of the most
popular FCN architectures for medical image segmentation, which is a encoder-decoder
network with additional short connection between encoder and decoder paths. Based
on the fact that a pancreas only takes up a small fraction of the whole scan, Zhou
et al. [30] proposed to find the rough pancreas region and then learn a FCN based
fixed-point model to refine the pancreas region iteratively. Their method is also based
on a coarse-to-fine framework, but it only considered coarse-to-fine RoIs. Besides
coarse-to-fine RoIs, our coarse-to-fine method also takes coarse-to-fine overlap sizes
into account, which is designed specifically for efficient 3D inference.
2.1.2 3D CNNs for Segmentation
Although 2D CNNs based methods achieved considerable progresses, they are not
optimal for medical image segmentation, as they cannot make full use of the 3D context
encoded in volumetric data. Several 3D CNNs based segmentation methods have been
proposed. The 3D U-Net [10] extended the previous 2D U-Net architecture [36] by
replacing all 2D operations with their 3D counterparts. Based on the architecture
of the 3D U-Net, the V-Net [11] introduced residual structures [61] (short term skip
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connection) into each stage of the network. Chen et al [33] proposed a deep voxel-wise
residual network for 3D brain segmentation. Both I2I-3D [62] and 3D-DSN [37]
included auxiliary supervision via side outputs into their 3D deep networks. Despite
the success of 3D CNNs as a technique for segmenting the target organs, such as
prostate [11] and kidney [10], very few techniques have been developed for leveraging
3D spatial information on the challenging pancreas segmentation. Gibson et al. [63]
proposed the DenseVNet which is however constrained to have shallow encoders due
to the computationally demanding dense connections.
2.1.3 2D and 3D CNNs Fusion for Segmentation
A few recent works have been proposed to combine 2D and 3D FCNs as a compromise
to leverage the advantages of both sides. VFN [64] adopted a 3D FCN by feeding
the segmentation predictions of 2D FCNs as input together with 3D images. H-
DenseUNet [65] hybridized a 2D DenseUNet for extracting intra-slice features and
a 3D counterpart for aggregating inter-slice contexts. Most recently, nnUNet [66]
proposed to ensemble 2D U-Net, 3D U-Net, and cascaded 3D U-Net in order to deal
with the data diversity. However, 2D CNNs and 3D CNNs are not optimized at the
same time in [64]–[66].
2.2 Neural Architecture Search
Neural Architecture Search (NAS) is the process of automatically discovering better
neural architectures than human designs. We summarize the progress in along two
dimensions: search algorithm and dataset/task.
Many NAS algorithms belong to either reinforcement learning or evolutionary
algorithm. In the reinforcement learning formulation [67], the actions generated by
an agent define the network architecture, and the reward is the accuracy on the
validation set. In the evolutionary formulation [68], architectures are mutated to
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produce better offsprings, again measured by validation accuracy. Although these
algorithms are general, they are usually computationally costly. To address this
problem, [69] progressively expand the search space in order to achieve better sample
efficiency. Differentiable NAS approaches [42], [43], [70] utilize sharing among candidate
architectures, and are arguably the most efficient family of algorithms to date.
At the same time, we also notice that the earlier papers [71]–[73] focused solely
on MNIST or CIFAR10 dataset. Later, [67]–[69] searched for “transferable archi-
tectures” from the smaller CIFAR10 to the much larger ImageNet dataset. More
recently, [74], [75] demonstrated the possibility to directly search for architectures
on the ImageNet dataset. Finally, [42] extended NAS beyond image classification to
semantic segmentation.
2.3 Lymph Node Detection and Segmentation
2.3.1 Generic Lesion Detection
There are two popular approaches for generic lesion detection: end-to-end [76]–[79] and
two-stage methods [80]–[83]. End-to-end methods have been extensively applied to the
universal lesion detection task in the largest general lesion dataset currently available,
i.e., DeepLesion [2], and achieved encouraging performance. Notably, a multi-task
universal lesion analysis network (MULAN) [78] so far achieves the best detection
accuracy using a 3D feature fusion strategy and Mask R-CNN [84] architecture.
In contrast, two-stage methods explicitly divide the detection task into candidate
generation and FP reduction steps. The first step generates the initial candidates
at a high recall and FP rate and the second step focuses on reducing the FP rate
(especially the difficult ones) while maintaining a sufficient high recall. It decouples
the task into easier sub-tasks and allows for the optimal design of each sub-task,
which has shown to be more effective in problems like lung nodule [80], [83] and brain
17
lacune [81] detection as compared to the one-stage method. We adopt the two-stage
strategy for the OSLN detection to effectively incorporate different features, i.e., PET
imaging, tumor distance map and high-semantic lesion attributes, into each stage.
We demonstrate the necessity of our strategy by comparing with the state-of-the-art
(SOTA) universal lesion detector MULAN [78] in the experiment.
2.3.2 Lymph Node Detection and Segmentation
All previous works focus only on enlarged LN detection and segmentation in contrast-
enhanced CT. Conventional statistical learning approaches [48]–[50], [55] employ
hand-crafted image features, such as shape, spatial priors, Haar filters, and volumetric
directional difference filters, to capture LN appearance and location. More recent
deep learning methods achieve better performance. [47], [51], [52] applies the FCN
or Mask R-CNN to directly segment LNs. In contrast, [7], [53] proposed a 2.5D
patch-based convolutional neural network (CNN) with random view aggregation to
classify LNs given all LN candidates already detected, and achieves state-of-the-art
(SOTA) classification accuracy for enlarged LNs. In Chapter 7, we demonstrate the
effectiveness of the local and global modules in our GLNet compared with the 2.5D
classification method [7].
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Chapter 3
A 3D Coarse-to-Fine Framework
for Volumetric Medical Image
Segmentation
In this chapter, we adopt 3D Convolutional Neural Networks to segment volumetric
medical images. Although deep neural networks have been proven to be very effective
on many 2D vision tasks, it is still challenging to apply them to 3D tasks due to
the limited amount of annotated 3D data and limited computational resources. We
propose a novel 3D-based coarse-to-fine framework to effectively and efficiently
tackle these challenges. The proposed 3D-based framework outperforms the 2D
counterpart to a large margin since it can leverage the rich spatial information along
all three axes. We conduct experiments on two datasets which include healthy and
pathological pancreases respectively, and achieve the current state-of-the-art in terms
of Dice-Sørensen Coefficient (DSC). On the NIH pancreas segmentation dataset, we
outperform the previous best by an average of over 2%, and the worst case is improved
by 7% to reach almost 70%, which indicates the reliability of our framework in clinical
applications.
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3.1 Introduction
Driven by the huge demands for computer-aided diagnosis systems, automatic organ
segmentation from medical images, such as computed tomography (CT) and magnetic
resonance imaging (MRI), has become an active research topic in both the medical
image processing and computer vision communities. It is a prerequisite step for many
clinical applications, such as diabetes inspection, organic cancer diagnosis, and surgical
planning. Therefore, it is well worth exploring automatic segmentation systems to
accelerate the computer-aided diagnosis in medical image analysis.
In this chapter, we focus on pancreas segmentation from CT scans, one of the most
challenging organ segmentation problems [30][18]. As shown in Fig. 3.1, the main
difficulties stem from three aspects: 1) the small size of the pancreas in the whole
abdominal CT volume; 2) the large variations in texture, location, shape and size of
the pancreas; 3) the abnormalities, like pancreatic cysts, can alter the appearance of
pancreases a lot.
Following the rapid development of deep neural networks [59][60] and their suc-
cesses in many computer vision tasks, such as semantic segmentation [31][26], edge
detection [85][27][86] and 3D shape retrieval [28][87], many deep learning based
methods have been proposed for pancreas segmentation and achieved considerable
progress [30][18][29]. However, these methods are based on 2D fully convolutional
networks (FCNs) [31], which perform segmentation slice by slice while CT volumes are
indeed 3D data. Although these 2D methods use strategies to fuse the output from
different 2D views to obtain 3D segmentation results, they inevitably lose some 3D
context, which is important for capturing the discriminative features of the pancreas
with respect to background regions.
Using 3D deep networks for organ segmentation is a recent trend but not yet
applied to the pancreas. An obstacle is that training 3D deep networks suffers from
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Figure 3.1. An illustration of normal pancreases on NIH dataset [18] and abnormal cystic
pancreases on JHMI dataset [88] shown in the first and second row respectively. Normal
pancreas regions are masked as red and abnormal pancreas regions are marked as blue.
The pancreas usually occupies a small region in a whole CT scan. Best viewed in color.
the “out of memory” problem. 2D FCNs can accept a whole 2D slice as input, but
3D FCNs cannot be fed a whole 3D volume due to the limited GPU memory size.
A common solution is to train 3D FCNs from small sub-volumes and test them in
a sliding-window manner [11][32][10][33][34], i.e., performing 3D segmentation on
densely and uniformly sampled sub-volumes one by one. Usually, these neighboring
sampled sub-volumes overlap with each other to improve the robustness of the final 3D
results. It is worth noting that the overlap size is a trade-off between the segmentation
accuracy and the time cost. Setting a larger/smaller overlap size generally leads to a
better/worse segmentation accuracy but takes more/less time during testing.
To address these issues, we propose a concise and effective framework based on
3D deep networks for pancreas segmentation, which can simultaneously achieve high
segmentation accuracy and low time cost. Our framework is formulated in a coarse-
to-fine manner. In the training stage, we first train a 3D FCN from the sub-volumes
sampled from an entire CT volume. We call this ResDSN Coarse model, which
aims to obtain the rough location of the target pancreas from the whole CT volume
by making full use of the overall 3D context. Then, we train another 3D FCN from
the sub-volumes sampled only from the ground truth bounding boxes of the target
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pancreas. We call this the ResDSN Fine model, which can refine the segmentation
based on the coarse result. In the testing stage, we first apply the coarse model in the
sliding-window manner to a whole CT volume to extract the most probable location
of the pancreas. Since we only need a rough location for the target pancreas in this
step, the overlap size is set to a small value. Afterwards, we apply the fine model
in the sliding-window manner to the coarse pancreas region, but by setting a larger
overlap size. Thus, we can efficiently obtain a fine segmentation result and we call the
coarse-to-fine framework by ResDSN C2F .
Note that, the meaning of “coarse-to-fine” in our framework is twofold. First, it
means the input region of interests (RoIs) for ResDSN Coarse model and ResDSN
Fine model are different, i.e., a whole CT volume for the former one and a rough
bounding box of the target pancreas for the latter one. We refer to this as coarse-to-fine
RoIs, which is designed to achieve better segmentation performance. The coarse step
removes a large amount of the unrelated background region, then with a relatively
smaller region to be sampled as input, the fine step can much more easily learn cues
which distinguish the pancreas from the local background, i.e., exploit local context
which makes it easier to obtain a more accurate segmentation result. Second, it means
the overlap sizes used for ResDSN Coarse model and ResDSN Fine model during
inference are different, i.e., small and large overlap sizes for them, respectively. We
refer to this as coarse-to-fine overlap sizes, which is designed for efficient 3D inference.
To our best knowledge, we are one of the first studies to segment the challenging
normal and abnormal pancreases using 3D networks which leverage the rich spatial
information. The effectiveness and efficiency of the proposed 3D coarse-to-fine frame-
work are demonstrated on two pancreas segmentation datasets where we achieve the
state-of-the-art with relative low time cost. It is worth mentioning that, although our
focus is pancreas segmentation, our framework is generic and can be directly applied
to segmenting other medical organs.
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Figure 3.2. Flowchart of the proposed 3D coarse-to-fine segmentation system in the
testing phase. We first apply “ResDSN Coarse” with a small overlapped sliding window
to obtain a rough pancreas region and then use the “ResDSN Fine” model to refine the
results with a large overlapped sliding window. Best viewed in color.
3.2 Related Work
The medical image analysis community is facing a revolution brought by the fast devel-
opment of deep networks [59][60]. Deep Convolutional Neural Networks (CNNs) based
methods have dominated the research area of volumetric medical image segmentation
in the last few years. Generally speaking, CNN-based methods for volumetric medical
image segmentation can be divided into two major categories: 2D CNNs based and
3D CNNs based.
3.2.1 2D CNNs for Volumetric Segmentation
2D CNNs based methods [18][29][89][90][36] performed volumetric segmentation slice
by slice from different views, and then fused the 2D segmentation results to obtain a 3D
Volumetric Segmentation result. In the early stage, the 2D segmentation based models
were trained from image patches and tested in a patch by patch manner [18], which is
time consuming. Since the introduction of fully convolution networks (FCNs) [31],
almost all the 2D segmentation methods are built upon 2D FCNs to perform holistic
slice segmentation during both training and testing. Havaei et al [89] proposed a two-
pathway FCN architecture, which exploited both local features as well as more global
contextual features simultaneously by the two pathways. Roth et al [29] performed
Pancreas segmentation by a holistic learning approach, which first segment pancreas
regions by holistically-nested networks [27] and then refine them by the boundary
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maps obtained by robust spatial aggregation using random forest. The U-Net [36] is
one of the most popular FCN architectures for medical image segmentation, which is
a encoder-decoder network, but with additional short connection between encoder and
decoder paths. Based on the fact that a pancreas only takes up a small fraction of the
whole scan, Zhou et al. [30] proposed to find the rough pancreas region and then learn
a FCN based fixed-point model to refine the pancreas region iteratively. Their method
is also based on a coarse-to-fine framework, but it only considered coarse-to-fine RoIs.
Besides coarse-to-fine RoIs, our coarse-to-fine method also takes coarse-to-fine overlap
sizes into account, which is designed specifically for efficient 3D inference.
3.2.2 3D CNNs for Volumetric Segmentation
Although 2D CNNs based methods achieved considerable progresses, they are not
optimal for medical image segmentation, as they cannot make full use of the 3D context
encoded in volumetric data. Several 3D CNNs based segmentation methods have been
proposed. The 3D U-Net [10] extended the previous 2D U-Net architecture [36] by
replacing all 2D operations with their 3D counterparts. Based on the architecture
of the 3D U-Net, the V-Net [11] introduced residual structures [61] (short term skip
connection) into each stage of the network. Chen et al [33] proposed a deep voxel-wise
residual network for 3D brain segmentation. Both I2I-3D [62] and 3D-DSN [37]
included auxiliary supervision via side outputs into their 3D deep networks. Despite
the success of 3D CNNs as a technique for segmenting the target organs, such as
prostate [11] and kidney [10], very few techniques have been developed for leveraging
3D spatial information on the challenging pancreas segmentation. Gibson et al. [63]
proposed the DenseVNet which is however constrained to have shallow encoders due
to the computationally demanding dense connections. Roth et al. [91] extended 3D
U-Net to segment pancreas, which has the following shortcomings, 1) the input of
their networks is fixed to 120 × 120 × 120, which is very computationally demanding
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due to this large volume size, 2) the rough pancreas bounding box is resampled to a
fixed size as their networks input, which loses information and flexibility, and cannot
deal with the intrinsic large variations of pancreas in shape and size. Therefore, we
propose our 3D coarse-to-fine framework that works on both normal and abnormal to
ensure both low computation cost and high pancreas segmentation accuracy.
3.3 Method
In this section, we elaborate our proposed 3D coarse-to-fine framework which includes
a coarse stage and a fine stage afterwards. We first formulate a segmentation model
that can be generalized to both coarse stage and fine stage. Later in Sec. 3.3.1 and
Sec. 3.3.2, we will customize the segmentation model to these two stages, separately.
We denote a 3D CT-scan volume by X. This is associated with a human-labeled
per-voxel annotation Y, where both X and Y have size W ×H ×D, which corresponds
to axial, sagittal and coronal views, separately. The ground-truth segmentation mask Y
has a binary value yi, i = 1, · · · , WHD, at each spatial location i where yi = 1 indicates
that xi is a pancreas voxel. Denote a segmentation model by M : P = f(X; Θ), where
Θ indicates model parameters and P means the binary prediction volume. Specifically
in a neural network with L layers and parameters Θ = {W , B}, W is a set of weights
and B is a set of biases, where W = {W1, W2, · · · , WL} and B = {B1, B2, · · · , BL}.
Given that p(yi|xi; Θ) represents the predicted probability of a voxel xi being what is
the labeled class at the final layer of the output, the negative log-likelihood loss can
be formulated as:
L = L(X; Θ) = −
∑︂
xi∈X
log(p(yi|xi; Θ)). (3.1)
It is also known as the cross entropy loss in our binary segmentation setting. By
thresholding p(yi|xi; Θ), we can obtain the binary segmentation mask P.
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We also add some auxiliary layers to such a neural network (will be called main-
stream network in the rest of the paper), which produces side outputs under deep
supervision [92]. These auxiliary layers form a branch network and facilitate the
feature learning at lower layer of the mainstream network. Each branch network
shares the weights of the first d layers from the mainstream network, which is denoted
by Θd = {Wd, Bd}. Apart from the shared weights, it owns weights ˆ︂Θd to output the
per-voxel prediction. Similarly, the loss of an auxiliary network can be formulated as:
Ld(X; Θd, ˆ︂Θd) = ∑︂
xi∈X
− log(p(yi|xi; Θd, ˆ︂Θd)), (3.2)
which is abbreviated as Ld. Finally, stochastic gradient descent is applied to minimize
the negative log-likelihood, which is given by following regularized objective function:
Loverall = L +
∑︂
d∈D
ξdLd + λ(∥Θ∥2 +
∑︂
d∈D
∥ˆ︂Θd∥)2, (3.3)
where D is a set of branch networks for auxiliary supervisions, ξd balances the
importance of each auxiliary network and l2 regularization is added to the objective
to prevent the networks from overfitting. For conciseness concerns in the following
sections, we keep a segmentation model that is obtained from the overall function
described in Eq. 3.3 denoted by M : P = f(X; Θ), where Θ includes parameters of
the mainstream network and auxiliary networks.
3.3.1 Coarse Stage
In the coarse stage, the input of “ResDSN Coarse” is sampled from the whole CT-
scan volume denoted by XC, on which the coarse segmentation model MC : PC =
fC
(︂
XC; ΘC
)︂
is trained on. All the C superscripts depict the coarse stage. The goal of
this stage is to efficiently produce a rough binary segmentation PC from the complex
background, which can get rid of regions that are segmented as non-pancreas with a
high confidence to obtain an approximate pancreas volume. Based on this approximate
pancreas volume, we can crop from the original input XC with a rectangular cube
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derived from PC to obtain a smaller 3D image space XF, which is surrounded by
simplified and less variable context compared with XC. The mathematic definition of
XF is formulated as:
XF = Crop[XC ⊗ PC; PC, m], (3.4)
where ⊗ means an element-wise product. The function Crop[X; P, m] denotes cropping
X via a rectangular cube that covers all the 1’s voxels of a binary volume P added by
a padding margin m along three axes. Given P, the functional constraint imposed
on X is that they have exactly the same dimensionality in 3D space. The padding
parameter m is empirically determined in experiments, where it is used to better
segment the boundary voxels of pancreas during the fine stage. The Crop operation
acts as a dimensionality reduction to facilitate the fine segmentation, which is crucial
to cut down the consuming time of segmentation. It is well-worth noting that the
3D locations of the rectangular cube which specifies where to crop XF from XC is
recorded to map the fine segmentation results back their positions in the full CT
scan.
3.3.2 Fine Stage
In the fine stage, the input of the ConvNet is sampled from the cropped volume XF,
on which we train the fine segmentation model MF : PF = fF
(︂
XF; ΘF
)︂
, where the
F superscripts indicate the fine stage. The goal of this stage is to refine the coarse
segmentation results from previous stage. In practice, PF has the same volumetric
size of XF, which is smaller than the original size of XC.
3.3.3 Coarse-to-Fine Segmentation
Our segmentation task is to give a volumetric prediction on every voxel of XC, so we
need to map the PF back to exactly the same size of XC given by:
PC2F = DeCrop[PF ⊙ PC; XF, XC], (3.5)
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Figure 3.3. Illustration of our 3D convolutional neural network for volumetric segmentation.
The encoder path is composed from “Conv1a” to “Conv4b” while the decoder path is
from “DeConv3a” to “Res/Conv1b”. Each convolution or deconvolution layer consists of
one convolution followed by a BatchNorm and a ReLU. To clarify, “Conv1a, 32, 3 × 3 × 3”
means the convolution operation with 32 channels and a kernel size of 3 × 3 × 3. “Pooling
1, max, 2” means the max pooling operation with kernel size of 2 × 2 × 2 and a stride
of two. Long residual connections are illustrated by the blue concrete lines. Blocks with
same color mean the same operations. Best viewed in color.
where PC2F denotes the final volumetric segmentation, and ⊙ means an element-wise
replacement, and DeCrop operation defined on PF, PC, XF and XC is to replace a
pre-defined rectangular cube inside PC by PF, where the replacement locations are
given by the definition of cropping XF from XC given in Eq. 3.4.
All in all, our entire 3D-based coarse-to-fine segmentation framework during testing
is illustrated in Fig 3.2.
3.3.4 Network Architecture
As shown in Fig. 3.3, we provide an illustration of our convolutional network architec-
ture. Inspired by V-Net [11], 3D U-Net [10], and VoxResNet [33], we have an encoder
path followed by a decoder path each with four resolution steps. The left part of
network acts as a feature extractor to learn higher and higher level of representations
while the right part of network decompresses compact features into finer and finer
resolution to predict the per-voxel segmentation. The padding and stride of each layer
(Conv, Pooling, DeConv) are carefully designed to make sure the densely predicted
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output is the same size as the input.
The encoder sub-network on the left is divided into different steps that work
on different resolutions. Each step consists of one to two convolutions, where each
convolution is composed of 3 × 3 × 3 convolution followed by a batch normalization
(BN [93]) and a rectified linear unit (ReLU [94]) to reach better convergence, and then a
max pooling layer with a kernel size of 2×2×2 and strides of two to reduce resolutions
and learn more compact features. The downsampling operation implemented by
max-pooling can reduce the size of the intermediate feature maps while increasing the
size of the receptive fields. Having fewer size of activations makes it possible to double
the number of channels during feature aggregation given the limited computational
resource.
The decoder sub-network on the right is composed of several steps that operate on
different resolutions as well. Each step has two convolutions with each one followed
by a BatchNorm and a ReLU, and afterwards a Deconvolution with a kernel size of
4×4×4 and strides of two is connected to expand the feature maps and finally predict
the segmentation mask at the last layer. The upsampling operation that is carried
out by deconvolution enlarges the resolution between each step, which increases the
size of the intermediate activations so that we need to halve the number of channels
due to the limited memory of the GPU card.
Apart from the left and right sub-networks, we impose a residual connection [61] to
bridge short-cut connections of features between low-level layers and high-level layers.
During the forward phase, the low-level cues extracted by networks are directly added
to the high-level cues, which can help elaborate the fine-scaled segmentation, e.g.,
small parts close to the boundary which may be ignored during the feature aggregation
due to the large size of receptive field at high-level layers. As for the backward phase,
the supervision cues at high-level layers can be back-propagated through the short-cut
way via the residual connections. This type of mechanism can prevent networks from
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Method Long Res Short Res Deep Super Loss
ResDSN (Ours) Sum No Yes CE
FResDSN Sum Sum Yes CE
SResDSN No Sum Yes CE
3D U-Net [10] Concat No No CE
V-Net [11] Concat Sum No DSC
VoxResNet [33] No Sum Yes CE
MixedResNet [96] Sum Sum Yes CE
3D DSN [37] No No Yes CE
3D HED [62] Concat No Yes CE
Table 3.1. Configurations comparison of different 3D segmentation networks on medical
image analysis. For all the abbreviated phrases, “Long Res” means long residual connection,
“Short Res” means short residual connection, “Deep Super” means deep supervision
implemented by auxiliary loss layers, “Concat” means concatenation, “DSC” means Dice-
Sørensen Coefficient and “CE” means cross-entropy. For residual connection, it has two
types: concatenation (“Concat”) or element-wise sum (“Sum”).
gradient vanishing and exploding [95], which hampers network convergence during
training.
We have one mainstream loss layer connected from “Res/Conv1b” and another
two auxiliary loss layers connected from “Conv2b” and “Conv3b” to the ground truth
label, respectively. For the mainstream loss in “Res/Conv1b” as the last layer which
has the same size of data flow as one of the input, a 1 × 1 × 1 convolution is followed
to reduce the number of channels to the number of label classes which is 2 in our case.
As for the two auxiliary loss layers, deconvolution layers are connected to upsample
feature maps to be the same as input.
The deep supervision imposed by auxiliary losses provides robustness to hyper-
parameters choice, in that the low-level layers are guided by the direct segmentation
loss, leading to faster convergence rate. Throughout this work, we have two auxiliary
branches where the default parameters are ξ1 = 0.2 and ξ2 = 0.4 in Eq. 3.3 to control
the importance of deep supervisions compared with the major supervision from the
mainstream loss for all segmentation networks.
As shown in Table 3.1, we give the detailed comparisons of network configurations
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in terms of four aspects: long residual connection, short residual connection, deep
supervision and loss function. Our backbone network architecture, named as “Res-
DSN”, is proposed with different strategies in terms of combinations of long residual
connection and short residual connection compared with VoxResNet [33], 3D HED [62],
3D DSN [37] and MixedResNet [96]. In this table, we also depict “FResDSN” and
“SResDSN”, where “FResDSN” and “SResDSN” are similar to MixedResNet [96]
and VoxResNet [33], respectively. As confirmed by our quantitative experiments
in Sec. 3.4.4.1, instead of adding short residual connections to the network, e.g.,
“FResDSN” and “SResDSN”, we only choose the long residual element-wise sum,
which can be more computationally efficient while even performing better than the
“FResDSN” architecture which is equipped with both long and short residual connec-
tions. Moreover, ResDSN has noticeable differences with respect to the V-Net [11]
and 3D U-Net [10]. On the one hand, compared with 3D U-Net and V-Net which
concatenate the lower-level local features to higher-level global features, we adopt the
element-wise sum between these features, which outputs less number of channels for
efficient computation. On the other hand, we introduce deep supervision via auxiliary
losses into the network to yield better convergence.
3.4 Experiments
In this section, we first describe in detail how we conduct training and testing
in the coarse and fine stages, respectively. Then we are going to compare our
proposed method with previous state-of-the-art on two pancreas datasets: NIH
pancreas dataset [18] and JHMI pathological pancreas dataset [88].
3.4.1 Network Training and Testing
All our experiments were run on a desktop equipped with the NVIDIA TITAN X
(Pascal) GPU and deep neural networks were implemented based on the CAFFE [97]
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platform customized to support 3D operations for all necessary layers, e.g., “convo-
lution”, “deconvolution” and “pooling”, etc. For the data pre-processing, we simply
truncated the raw intensity values to be in [−100, 240] and then normalized each
raw CT case to have zero mean and unit variance to decrease the data variance
caused by the physical processes [98] of medical images. As for the data augmentation
in the training phase, unlike sophisticated processing used by others, e.g., elastic
deformation [11][36], we utilized simple but effective augmentations on all training
patches, i.e., rotation (90°, 180°, and 270°) and flip in all three axes (axial, sagittal
and coronal), to increase the number of 3D training samples which can alleviate the
scarce of CT scans with expensive human annotations. Note that different CT cases
have different physical resolutions, but we keep their resolutions unchanged. The input
size of all our networks is denoted by WI × HI × DI , where WI = HI = DI = 64.
For the coarse stage, we randomly sampled 64×64×64 sub-volumes from the whole
CT scan in the training phase. In this case, a sub-volume can either cover a portion of
pancreas voxels or be cropped from regions with non-pancreas voxels at all, which acts
as a hard negative mining to reduce the false positive. In the testing phase, a sliding
window was carried out to the whole CT volume with a coarse stepsize that has small
overlaps within each neighboring sub-volume. Specifically, for a testing volume with a
size of W ×H ×D, we have a total number of (⌊ W
WI
⌋+n)× (⌊ H
HI
⌋+n)× (⌊ D
DI
⌋+n) sub-
volumes to be fed into the network and then combined to obtain the final prediction,
where n is a parameter to control the sliding overlaps that a larger n results in a
larger overlap and vice versa. In the coarse stage for the low time cost concern, we
set n = 6 to efficiently locate the rough region of pancreas XF defined in Eq. 3.4 from
the whole CT scan XC.
For the fine stage, we randomly cropped 64 × 64 × 64 sub-volumes constrained
to be from the pancreas regions defined by ground-truth labels during training. In
this case, a training sub-volume was assured to cover pancreatic voxels, which was
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specifically designed to be capable of segmentation refinement. In the testing phase,
we only applied the sliding window on XF with a size of WF × HF × DF . The total
number of sub-volumes to be tested is (⌊WF
WI
⌋ + n) × (⌊HF
HI
⌋ + n) × (⌊DF
DI
⌋ + n). In the
fine stage for the high accuracy performance concern, we set n = 12 to accurately
estimate the pancreatic mask PF from the rough segmentation volume XF. In the end,
we mapped the PF back to PC to obtain PC2F for the final pancreas segmentation as
given in Eq. 3.5, where the mapping location is given by the cropped location of XF
from XC.
After we get the final binary segmentation mask, we denote P and Y to be the set
of pancreas voxels in the prediction and ground truth, separately, i.e., P = {i|pi = 1}
and Y = {i|yi = 1}. The evaluation metric is defined by the Dice-Sørensen Coefficient
(DSC) formulated as DSC(P , Y) = 2×|P∩Y||P|+|Y| . This evaluation measurement ranges in
[0, 1] where 1 means a perfect prediction.
3.4.2 NIH Pancreas Dataset
We conduct experiments on the NIH pancreas segmentation dataset [18], which contains
82 contrast-enhanced abdominal CT volumes provided by an experienced radiologist.
The size of CT volumes is 512 × 512 × D, where D ∈ [181, 466] and their spatial
resolutions are w × h × d, where d = 1.0mm and w = h that ranges from 0.5mm to
1.0mm. Data pre-processing and data augmentation were described in Sec. 3.4.1. Note
that we did not normalize the spatial resolution into the same one since we wanted to
impose the networks to learn to deal with the variations between different volumetric
cases. Following the training protocol [18], we perform 4-fold cross-validation in a
random split from 82 patients for training and testing folds, where each testing fold
has 21, 21, 20 and 20 cases, respectively. We trained networks illustrated in Fig. 3.3 by
SGD optimizer with a 16 mini-batch, a 0.9 momentum, a base learning rate to be 0.01
via polynomial decay (the power is 0.9) in a total of 80,000 iterations, and the weight
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Method Mean DSC Max DSC Min DSC
ResDSN C2F (Ours) 84.59± 4.86% 91.45% 69.62%
ResDSN Coarse (Ours) 83.18 ± 6.02% 91.33% 58.44%
Cai et al. [35] 82.4 ± 6.7% 90.1% 60.0%
Zhou et al. [30] 82.37 ± 5.68% 90.85% 62.43%
Dou1 et al. [37] 82.25 ± 5.91% 90.32% 62.53%
Roth et al. [29] 78.01 ± 8.20% 88.65% 34.11%
Yu1 et al. [34] 71.96 ± 15.34% 89.27% 0%
Table 3.2. Evaluation of different methods on the NIH dataset. Our proposed framework
achieves state-of-the-art by a large margin compared with previous state-of-the-arts.
decay 0.0005. Both training networks in the coarse and fine stages shared the same
training parameter settings except that they took a 64 × 64 × 64 input sampled from
different underlying distributions described in Sec. 3.4.1, which included the details
of testing settings as well. We average the score map of overlapped regions from the
sliding window and throw away small isolated predictions whose portions are smaller
than 0.2 of the total prediction, which can remove small false positives. For DSC
evaluation, we report the average with standard deviation, max and min statistics
over all 82 testing cases as shown in Table 3.2.
First of all, our overall coarse-to-fine framework outperforms previous state-of-the-
art by nearly 2.2% (Cai et al. [35] and Zhou et al. [30]) in terms of average DSC, which
is a large improvement. The lower standard deviation of DSC shows that our method
is the most stable and robust across all different CT cases. Although the enhancement
of max DSC of our framework is small due to the saturation, the improvement of min
DSC over the second best (Dou et al. [37]) is from 62.53% to 69.62%, which is a more
than 7% advancement. The worst case almost reaches 70%, which is a reasonable and
acceptable segmentation result. After coarse-to-fine, the segmentation result of the
worst case is improved by more than 11% after the 3D-based refinement from the
3D-based coarse result. The overall average DSC was also improved by 1.41%, which
1The results are reported by our runs using the same cross-validation splits where code is available
from their GitHub: https://github.com/yulequan/HeartSeg.
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#33 Coarse 58.44% #33 C2F 69.62% #63 Coarse 74.63% #63 C2F 84.87% #74 Coarse 90.84% #74 C2F 91.03%
Figure 3.4. Examples of segmentation results reported by “ResDSN Coarse” and “ResDSN
C2F” on a same slice in the axial view from NIH case #33, #63 and #74, respectively.
Numbers after “Coarse” or “C2F” mean testing DSC. Red, green and yellow indicate the
ground truth, prediction and overlapped regions, respectively. Best viewed in color.
proves the effectiveness of our framework.
As shown in Fig 3.4, we report the segmentation results by “ResDSN Coarse”
and “ResDSN C2F” on the same slice for comparison. Note that yellow regions are
the correctly predicted pancreas. For the NIH case #33, which is the min DSC
case reported by both “ResDSN Coarse” and “ResDSN C2F”, the “ResDSN C2F”
successfully predict more correct pancreas regions at the bottom, which is obviously
missed by “ResDSN Coarse”. If the coarse segmentation is bad, e.g., case #33 and
#63, our 3D coarse-to-fine can significantly improve the segmentation results by as
much as 10% in DSC. However, if the coarse segmentation is already very good, e.g.,
case #74, our proposed method cannot improve too much. We conclude that our
proposed “ResDSN C2F” shows its advancement over 2D methods by aggregating rich
spatial information and is more powerful than other 3D methods on the challenging
pancreas segmentation task.
3.4.3 JHMI Pathological Pancreas Dataset
We verified our proposed idea on the JHMI pathological cyst dataset [88] of abdominal
CT scans as well. Different from the NIH healthy pancreas dataset, this dataset includes
pathological cysts where some can be or can become cancerous. The pancreatic cancer
stage largely influences the morphology of the pancreas [99] that makes this dataset
extremely challenging for considering the large variants.
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Method Mean DSC
ResDSN C2F (Ours) 80.56± 13.36%
ResDSN Coarse (Ours) 77.96 ± 13.36%
Zhou et al. [88] 79.23 ± 9.72%
Table 3.3. Evaluations on the JHMI pathological pancreas.
This dataset has a total number of 131 contrast-enhanced abdominal CT volumes
with human-labeled pancreas annotations. The size of CT volumes is 512 × 512 × D,
where D ∈ [358, 1121] that spans a wider variety of thickness than one of the NIH
dataset. Following the training protocol [88], we conducted 4-fold cross validation on
this dataset where each testing fold has 33, 33, 32 and 33 cases, respectively. We trained
networks illustrated in Fig. 3.3 in both the coarse and fine stage with the same
training settings as on the NIH except that we trained a total of 300,000 iterations on
this pathological dataset since a pancreas with cysts is more difficult to segment than
a normal case. In the testing phase, we vote the prediction map of overlapped regions
from the sliding window and ignore small isolated pancreas predictions whose portions
are smaller than 0.05 of the total prediction. As shown in Table. 3.3, we compare
our framework with only one available published results on this dataset. “ResDSN
C2F” achieves an average 80.56% DSC that consistently outperforms the 2D based
coarse-to-fine method [88], which confirms the advantage of leveraging the rich spatial
information along three axes. What’s more, the “ResDSN C2F” improves the “ResDSN
Coarse” by 2.60% in terms of the mean DSC, which is a remarkable improvement
that proves the effectiveness of the proposed 3D coarse-to-fine framework. Both [88]
and our method have multiple failure cases whose testing DSC are 0, which indicates
the segmentation of pathological organs is a more tough task. Due to these failure
cases, we observe a large deviation on this pathological pancreas dataset compared
with results on the NIH healthy pancreas dataset.
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Method Mean DSC Max DSC Min DSC
ResDSN Coarse (Ours) 83.18± 6.02% 91.33% 58.44%
FResDSN Coarse 83.11 ± 6.53% 91.34% 61.97%
SResDSN Coarse 82.82 ± 5.97% 90.33% 62.43%
DSN [37] Coarse 82.25 ± 5.91% 90.32% 62.53%
Table 3.4. Evaluation of different residual connections on NIH.
3.4.4 Discussion
In this section, we conduct the ablation studies about residual connection, time
efficiency and deep supervision to further investigate the effectiveness and efficiency
of our proposed framework for pancreas segmentation.
3.4.4.1 Residual Connection
We discuss how different combinations of residual connections contribute to the
pancreas segmentation task on the NIH dataset. All the residual connections are im-
plemented in the element-wise sum and they shared exactly the same deep supervision
connections, cross-validation splits, data input, training and testing settings except
that the residual structure is different from each other. As given in Table. 3.4, we
compare four configurations of residual connections of 3D based networks only in the
coarse stage. The major differences between our backbone network “ResDSN” with
respect to “FResDSN”, “SResDSN” and “DSN” are depicted in Table. 3.1. “ResDSN”
outperforms other network architectures in terms of average DSC and a small standard
deviation even through the network is not as sophisticated as “FResDSN”, which is
the reason we adopt “ResDSN” for efficiency concerns in the coarse stage.
3.4.4.2 Time Efficiency
We discuss the time efficiency of the proposed coarse-to-fine framework with a smaller
overlap in the coarse stage for the low consuming time concern while a larger one
in the fine stage for the high prediction accuracy concern. The overlap size depends
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Method Mean DSC n Testing Time (s)
ResDSN C2F (Ours) 84.59± 4.86% 6&12 245
ResDSN Coarse (Ours) 83.18 ± 6.02% 6 111
ResDSN Fine (Ours) 83.96 ± 5.65% 12 382
Table 3.5. Average time cost in the testing phase, where n controls the overlap size of
sliding windows during the inference.
on how large we choose n defined in Sec 3.4.1. We choose n = 6 during the coarse
stage while n = 12 during the fine stage. Experimental results are shown in Table 3.5.
“ResDSN Coarse” is the most efficient while the accuracy is the worst among three
methods, which makes sense that we care more of the efficiency to obtain a rough
pancreas segmentation. “ResDSN Fine” is to use a large overlap on an entire CT
scan to do the segmentation which is the most time-consuming. In our coarse-to-fine
framework, we combine the two advantages together to propose “ResDSN C2F” which
can achieve the best segmentation results while the average testing time cost for
each case is reduced by 36% from 382s to 245s compared with “ResDSN Fine”. In
comparison, it takes an experienced board certified Abdominal Radiologist 20 mins
for one case, which verifies the clinical use of our framework.
3.4.4.3 Deep Supervision
We discuss how effective of the auxiliary losses to demonstrate the impact of the deep
supervision on our 3D coarse-to-fine framework. Basically, we train our mainstream
networks without any auxiliary losses for both coarse and fine stages, denoted as
“Res C2F”, while keeping all other settings as the same, e.g., cross-validation splits,
data pre-processing and post-processing. As shown in Table 3.6, “ResDSN C2F”
outperforms “Res C2F” by 17.79% to a large extent on min DSC and 0.53% better
on average DSC though it’s a little bit worse on max DSC. We conclude that 3D
coarse-to-fine with deep supervisions performs better and especially more stable on
the pancreas segmentation.
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Method Mean DSC Max DSC Min DSC
ResDSN C2F (Ours) 84.59± 4.86% 91.45% 69.62%
Res C2F 84.06 ± 6.51% 91.72% 51.83%
Table 3.6. Discussions of the deep supervision on NIH.
3.5 Conclusion and Future Works
In this work, we propose a novel 3D network called “ResDSN” integrated with a
coarse-to-fine framework to simultaneously achieve high segmentation accuracy and
low time cost. The backbone network “ResDSN” is carefully designed to only have
long residual connections for efficient inference. To our best knowledge, we are one of
the first works to segment the challenging pancreas using 3D networks which leverage
the rich spatial information to achieve the state-of-the-art. On widely-used datasets,
the worst segmentation case is experimentally improved a lot by our coarse-to-fine
framework. What’s more, our coarse-to-fine framework can work on both normal
and abnormal pancreases to achieve good segmentation accuracy. As future works,
there are two directions to explore. First, the network backbone can be further
advanced by the automatically searching the neural network architectures. Second,
current coarse-to-fine framework decouples the coarse and fine stages, whereas jointly
optimizing the segmentation networks in these two stages can further boost the overall
segmentation accuracy.
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Chapter 4
Multi-Scale Coarse-to-Fine
Segmentation for Screening
Pancreatic Ductal Adenocarcinoma
In this chapter, we propose an intuitive approach of detecting pancreatic ductal adeno-
carcinoma (PDAC), the most common type of pancreatic cancer, by checking abdom-
inal CT scans. Our idea is named multi-scale segmentation-for-classification,
which classifies volumes by checking if at least a sufficient number of voxels is seg-
mented as tumors, by which we can provide radiologists with tumor locations. In
order to deal with tumors with different scales, we train and test our volumetric
segmentation networks with multi-scale inputs in a coarse-to-fine flowchart. A post-
processing module is used to filter out outliers and reduce false alarms. We collect a
new dataset containing 439 CT scans, in which 136 cases were diagnosed with PDAC
and 303 cases are normal, which is the largest set for PDAC tumors to the best of our
knowledge. To offer the best trade-off between sensitivity and specificity, our proposed
framework reports a sensitivity of 94.1% at a specificity of 98.5%, which demonstrates
the potential to make a clinical impact.
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4.1 Introduction
Pancreatic cancer is one of the most dangerous killers to human lives, causing more
than 330,000 deaths globally in 2014 [22]. Pancreatic ductal adenocarcinoma (PDAC)
is the most common type of pancreatic cancer, accounting for about 85% of cancer
cases. In early stages, this disease often has few symptoms and is very difficult to
discover. By the time of diagnosis, the cancer has often spread to other parts of the
body, leading to a very poor prognosis (e.g., a five-year survival rate of 5% [22]). But,
for cases diagnosed early, the survival rate rises to about 20% [23]. Hence, it is very
important to study the possibility of detecting PDAC in common examinations, e.g.,
the abdominal CT scan.
The early diagnosis of pancreatic cancer requires much expertise in reading the
scanned images and making decisions, but the increasing number of cases makes it
impossible for a limited number of experienced radiologists to check all CT scans
manually. Therefore, an artificial intelligence system for this purpose is in need.
In particular, the radiologists in our team are interested in a system working on
abdominal CT scans, which filters out a large fraction of normal cases, but preserves
almost all abnormal cases for further investigation. To the best of our knowledge,
there is no existing work on this task.
With the development of deep learning [59], it is possible to construct a system
which learns from professional knowledge in data annotation, and apply it to helping
doctors in various clinical purposes. The pancreas is one of the most challenging
organs in CT segmentation [18]. The difficulty mainly lies in its irregular shape and
low contrast around the boundary. Powered by the recent progress in deep learning
for 2D [26][36] and 3D [11][64] image segmentation, researchers designed various
approaches [29][38] towards accurate pancreas segmentation. In the pathological cases,
the morphology of the pancreas can be largely impacted by the difference in the
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Figure 4.1. Examples of normal and abnormal (PDAC) pancreases (best viewed in color).
Blue and red region mark the normal pancreas and tumor regions, respectively.
pancreatic cancer stage [100][88].
Our work is aimed to detect PDAC from a mixture of normal and abnormal CT
scans. This is not a simple classification since radiologists also want to know the
location of PDAC, we suggest a solution named segmentation-for-classification,
which trains segmentation models and uses their outputs for classification. To deal
with tumors of various sizes (Fig. 4.1), we adopt a segmentation network with multiple
input scales, i.e., 643, 323 and 163 volumes. But, voting that small input regions
lead to a high false alarm rate, we adopt a coarse-to-fine testing strategy, which
uses the 643 network for a coarse scan, and then the 323&163 networks inside the
bounding box to detect small tumors that are possibly ignored in the previous stage.
A non-parameterized post-processing algorithm is designed to remove outliers.
Our contributions are three folds: 1) we voxelwisely annotate an abdominal
CT dataset with 439 cases in total, in which 136 cases are diagnosed with PDAC
while the remaining 303 cases are normal, which is currently the largest PDAC
dataset to the best of our knowledge; 2) we adopt a multi-scale segmentation-for-
classification framework to conduct an interpretable abnormality detection, which
provides radiologists with suspicious regions for further diagnosis; 3) our framework
achieves a sensitivity of 94.1% at a specificity of 98.5%, which shows a promising
direction to make a potential significant clinical impact.
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4.2 Method
4.2.1 The Overall Framework
Let a dataset be S = {(X1, y⋆1) , . . . , (XN , y⋆N)}, where N is the number of CT scans,
Xn ∈ RWn×Hn×Ln is the 3D volume with each element indicating the Hounsfield unit
(HU) of a voxel, and yn ∈ {0, 1} is the label (0 for a normal case, 1 for an abnormal
case). Throughout this paper, by abnormal we refer to the cases diagnosed as PDAC.
The goal is to design a model M : y = f(X) to predict the label for each testing
volume. We evaluate our approach by ranking all volumes by the probability of being
a PDAC, computing the sensitivity and specificity at a given threshold, and plotting
the ROC curve indicating the relationship between the sensitivity and specificity at
different thresholds. For clinical purposes, we shall guarantee a high sensitivity with a
reasonable specificity.
Although some previous work suggested to classify CT or MRI volumes directly
using 3D networks [101][102], we argue that a better solution is to perform tumor
segmentation at the same time of classification. This makes the classification results
interpretable by segmentation cues, by which radiologists can take a further inves-
tigation of the suspicious abnormal regions. In addition, this integrates voxel-wise
annotations into the classification model as deep supervision, so that the entire net-
work is better trained [88]. Therefore, we propose a two-stage framework named
segmentation-for-classification, in which a segmentation stage first extracts voxel-wise
cues from the input CT scan, and a classification stage follows to summarize this
information into the final prediction. Our multi-scale segmentation strategy is different
from [38], which applied another network of the same scale in the fine stage. Tumor
detection requires multiple scales.
Mathematically, let each training data be augmented by a segmentation mask M⋆n
of the same dimensionality as X, so that m⋆n,i ∈ {0, 1, 2} indicates the category of the
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Figure 4.2. The architecture of our segmentation backbone (best viewed in color). Each
rectangle is a layer, green arrows indicate operations changing spatial resolution, and red
arrows mean residual connections. We illustrate the situation when the input volume size is
643. If it is 323 or 163, all volumes are shrunk accordingly (to 1/23 or 1/43 of the displayed
size). The number at the upper-right corner of each cube is the number of channels. Each
convolution uses 3×3×3 kernels with 1 as stride, each pooling 2×2×2 with 2 as stride,
and each deconvolution 4×4×4 with 2 as stride. The weight ratio for auxiliary losses #1,
#2 and main loss is 1 : 2 : 5 for the 643 network, and 1 : 3 for the auxiliary loss #1 and
the main loss for the 323 and 163 networks.
i-th voxel, i.e., in the tumor (mn,i = 2), outside the tumor but inside the pancreas
(mn,i = 1), or outside the pancreas (mn,i = 0). Note that the tumor voxel set is a
subset of the pancreas voxel set. The segmentation module is a high-dimensional
function M = s(X), which is implemented by a deep encoder-decoder network. The
classification module is a binary function y = c(M). The overall framework is thus
written as:
y = f(X) = c ◦ s(X). (4.1)
4.2.2 Training: Multi-Scale Deeply-Supervised Segmentation
We start with describing the segmentation stage. The tumor region in a pancreas,
as shown in Fig. 4.1, can vary in scale, appearance and geometric properties. In
particular, the largest tumor in our dataset occupies over one million voxels, but the
smallest one has only thousands. This motivates us to train multi-scale networks to
deal with such a large variation in scale.
In practice, we train three networks, taking input volumes of 643, 323 and 163 voxels,
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respectively. Each segmentation network follows an encoder-decoder flowchart shown in
Fig. 4.2. It has a series of convolutional layers to learn 3D patterns from training data.
Down-sampling and up-sampling are implemented by max pooling and deconvolutional
layers, respectively. Following [38], we introduce deep supervision in the training
process, which is implemented by adding several auxiliary losses to intermediate layers,
which delivers better performance for the normal and cystic pancreas segmentation
in [38]. Deep supervision is considered as a way of incorporating multi-stage visual
cues, which constrains intermediate layers and improves the stability of training deep
networks. Multi-scale segmentation is complementary to deep supervision, which
aims at capturing visual patterns of various scales. As can be seen in experiments,
multi-scale segmentation can take advantage of different scales, i.e., a large network
produces a high specificity, and a small network gives a high sensitivity.
The training process starts with sampling patches of a specified size. Since the
pancreas and the tumor only occupy a small fraction of the entire volume, a random
sampling strategy may lead to that only few patches contain pancreas or tumor voxels,
and thus the segmentation models are biased towards the background class. To deal
with the issue, we sample lots of foreground patches for training the 323 and 163
networks. We first compute the region-of-interest (ROI) by padding a 32-voxel margin
around the minimal 3D bounding box covering the entire pancreas. Within it, we
categorize the randomly sampled patches into three types (i.e., background, tumor
and pancreas) according to the fraction of pancreas and tumor voxels, and make
the numbers of training patches of these types to be approximately the same. Data
augmentation is performed by randomly flipping patches and rotating by 90◦, 180◦
and 270◦ over three axes.
We use the same configuration for training these networks. The base learning rate
is 0.01 and decayed polynomially (the power is 0.9) in a total of 80,000 iterations (the
mini-batch size is 16, 32 and 128 for 643, 323 and 163, respectively). The weight decay
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and momentum are set to be 0.0005 and 0.9, respectively.
4.2.3 Testing: Coarse-to-Fine Segmentation
The first goal is to perform the pancreas and tumor segmentation. We first slide
a 643 window in the entire CT volume. The spatial stride is 20 along three axes,
which is chosen to have the average testing time for each case within 11 minutes on
a TITAN Xp GPU. Based on the coarse segmentation, we compute the ROI, i.e.,
the smallest box covering all pancreas and tumor voxels padded by 32, and crop the
CT image accordingly. Then, we scan the ROI with sliding windows of 323 and 163
voxels, and the strides are set to be 10 and 5, respectively. We do not run the two
small networks on the entire volume because it can easily hallucinate tumors in the
background regions. In addition, shrinking the scanning region for the 323 and 163
networks leads to a significant speedup in the testing process. The predictions of three
networks are averaged into final segmentation.
Then, based on the segmentation mask, we classify each volume as normal or
abnormal. Advised by the radiologists who desire the classification result to be
explainable, we do not formulate the classifier c(·) as another deep network, but use a
simple, non-parametrized approach to filter out the outliers. We construct a graph
on all voxels predicted as normal pancreas or tumor. Each voxel is a node, and there
exists an edge between the adjacent voxels (each voxel is adjacent to 6 neighbors).
We compute all connected component in the graph. A component is preserved if it is
larger than 20% of the maximal connected component, otherwise it is removed, i.e.,
all voxels within this component are predicted as background. To obtain our final
goal, a volume is predicted as PDAC if at least K voxels are predicted as tumor. In
practice, we empirically set K = 50.
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4.3 Experiments
4.3.1 Dataset and Settings
We collected a dataset with 303 normal cases from potential renal donors, as well as
136 biopsy-proven PDAC cases. Four experts in abdominal anatomy annotated the
pancreas and tumor voxels on these data using the Varian Velocity software, and each
case was checked by an experienced board-certified Abdominal Radiologist. For a
radiologist, an average normal case took 20 minutes, and an average abnormal case 40
minutes to segment. Since the abnormal cases are much harder to obtain and annotate
than the normal cases, we adopt a 4-fold cross-validation on our 136 PDAC scans
to have testing results on every abnormal case while we use a hard split of training
and testing on our 303 normal cases. All in all, each training set contains 103 normal
and 102 abnormal cases where the normal-to-abnormal ratio is close to 1, and each
testing set contains 34 abnormal and 200 normal cases. The average size of CT scans
is 512×512×667.
One goal is to measure the segmentation accuracy by the Dice-Sørensen Coeffi-
cient (DSC) between the predicted and the ground-truth tumor sets Y and Y⋆, i.e.,
DSC(Y , Y⋆) = 2 × |Y ∩ Y⋆|/(|Y| + |Y⋆|). Our main goal is the tumor classification,
which involves a tradeoff between sensitivity and specificity.
4.3.2 Segmentation Results
We first summarize the segmentation results in Table 4.1, which makes the normal v.s.
abnormal classification to be interpretable by segmentation cues. The 643 network
achieves reasonable pancreas and tumor segmentation accuracies. The segmentation
result of normal pancreas is as high as 86.9%, which means that the normal pancreases
are easier to segment, as there are often unpredicted changes in shape and geometry
in the abnormal cases. As a side comment, the lowest DSC of an abnormal pancreas is
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Scale N. Pancreas A. Pancreas Tumor Misses Sen Spe
643 86.9 ± 8.6% 81.0 ± 10.8% 57.3 ± 28.1% 10/136 92.7% 99.0%
323 82.0 ± 12.2% 75.7 ± 14.9% 53.8 ± 26.1% 7/136 94.9% 96.0%
163 61.5 ± 20.6% 64.1 ± 20.2% 42.5 ± 25.6% 4/136 97.1% 86.5%
Multi 84.5 ± 11.1% 78.6 ± 13.3% 56.5 ± 27.2% 8/136 94.1% 98.5%
Table 4.1. Comparison of segmentation and classification results by networks of different
scales and their combination. From left to right: normal/abnormal pancreas and tumor
segmentation accuracy (DSC, %), the number of missing tumors (i.e., DSC is 0%), and
the sensitivity (abbreviated as sen, and sen = 1 − miss rate) and specificity (abbreviated
as spe).
38.4%, lower than the number (44.0%) of a normal pancreas. In tumor segmentation,
we observe a lower accuracy and a higher standard deviation (57.3 ± 28.1%). Except
for the 10 missing cases, we find 20 more cases with a tumor DSC lower than 30%. All
these evidences imply the challenging of finding tumors considering their various size,
shape and locations. Note that a recent work on the pancreatic cyst segmentation
achieves a DSC of 63.4 ± 27.7% [88], which is not as hard as the tumor segmentation.
Going to smaller scales, fewer tumors are missed, though segmentation accuracies
become lower. This is the tradeoff between sensitivity and specificity: a network
with a smaller input region has the ability to detect tiny regions, but without seeing
contexts, it can be easily confused by false positives. Thus, combining multi-scale
predictions achieves a balance between sensitivity and specificity. Fig. 8.3 shows two
examples that benefit from multi-scale segmentation.
We replace our backbone with 3D UNet [10] and VNet [11] at the 643 scale setting
and report their results in Table 4.2 for comparison. We can find that the three
backbones perform roughly similar in terms of the segmentation results. However, our
backbone achieves the best results for the sensitivity and specificity.
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Method N. Pancreas A. Pancreas Tumor Misses Sen Spe
Ours 86.9 ± 8.6% 81.0 ± 10.8% 57.3 ± 28.1% 10/136 92.7% 99.0%
UNet 87.0 ± 8.4% 81.6 ± 10.2% 57.6 ± 27.8% 11/136 91.9% 99.0%
VNet 86.7 ± 8.8% 80.6 ± 11.4% 58.7 ± 28.0% 10/136 92.7% 98.0%
Table 4.2. Comparison of different networks as backbone at the 643 setting. The
sensitivity is abbreviated as sen and the specificity is abbreviated as spe.
Case #5012 643: 0.00% 323: 22.65% 163: 26.68% Multi: 12.24%
Case #5114 643: 24.96% 323: 61.94% 163: 25.15% Multi: 68.65%
Figure 4.3. Multi-scale segmentation examples (best viewed in color). Top: a case that
all three scales work well, and multi-scale combines them to achieve a higher DSC. Bottom:
a failure case in the 643 network, but found by the 323 and 163 networks. The yellow
frames indicate the zoomed-in regions, the blue and red contours mark the annotated
pancreas and tumor respectively, and the masked regions mark segmentation results.
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Figure 4.4. Left: three false alarm examples, in which the blue contour marks the
annotated pancreas, and the blue and red regions mark the predicted pancreas and tumor,
respectively. We use yellow arrows to indicate the detected tiny “tumors”. Right: the ROC
curve of multi-scale classification. This figure is best viewed in color.
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4.3.3 Classification Results
Finally, we summarize classification results in Table 4.1, which is the crucial goal of
making earlier diagnosis possible for doctors. Radiologists care more about a high
sensitivity since they don’t want to miss a patient who has an abnormal pancreas,
which inspires us to adopt a multi-scale strategy to improve the sensitivity while
keeping a reasonable specificity. The model with multi-scale information achieves
the best overall performance, i.e., a sensitivity of 94.1% at a specificity of 98.5%.
These high scores imply that tumor segmentation provide strong cues for PDAC
screening. We show all three false alarms in Fig. 4.4. The radiologists of our team
confirmed that 2 out of these 3 false positives have focal fatty infiltration in the
pancreas corresponding to the detected “tumors”. Focal fatty infiltration is difficult
for radiologists to distinguish from tumor in current clinical practice. In this case, the
predicted “false alarm” was not normal in view of our radiologists.
By augmenting our segmentation for classification framework with cues from
number of predicted tumor voxels since the more voxels predicted as PDAC the more
likely this case is abnormal, we can output a confident score for each case, indicating
the possibility that this case suffers PDAC. More specifically, a confidence score is
computed by a weighted sum of the volume size and the segmentation probability
of predicted tumor voxels. By sorting all testing cases according to their confident
scores, we obtain a ROC curve of sensitivity and specificity. From the ROC curve, we
can make different emphasis to change the tradeoff between sensitivity and specificity,
e.g., we can achieve a sensitivity of 98.5% at a specificity of 95.6%, or a specificity of
99.5% at a sensitivity of 94.1%.
50
4.4 Conclusion and Future Works
In this chapter, we study an important and challenging task, i.e., detecting pancreases
diagnosed with PDAC in abdominal CT scans. This topic is crucial in saving lives
from pancreatic cancer yet few studied before, possibly due to the lack of data. We
propose a segmentation-for-classification framework which trains a segmentation
network and performs interpretable abnormality classification by simply checking
the existence of tumor voxels in each testing volume. There are two key points to
improve classification accuracy, known as multi-scale network training and coarse-
to-fine testing. To offer a best trade-off between sensitivity and specificity on our own
collected dataset containing 303 normal and 136 PDAC cases, we achieve a sensitivity
of 94.1% at a specificity of 98.5%. The strong numbers show the promising direction
to make a significant impact in clinics for early detection of pancreatic cancer, which
would save lives. Future works will include the dual-phase information (arterial and
venous phases) since current segmentation for classification is only done on venous
phase. Another possible direction is to label and segment the dilated pancreatic duct
in the meantime since it is regarded as the sign of high risk for pancreatic cancers
considering the dilated pancreatic duct sometimes can be easier to locate than PDAC.
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Chapter 5
Segmentation for Classification of
Screening Pancreatic
Neuroendocrine Tumors
This work presents comprehensive results to detect in the early stage the pancreatic
neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the pancreas,
which are the second common type of pancreatic cancer, by checking the abdominal
CT scans. To the best of our knowledge, this task has not been studied before as
a computational task. To provide radiologists with tumor locations, we adopt a
segmentation framework to classify CT volumes by checking if at least a sufficient
number of voxels is segmented as tumors. To quantitatively analyze our method,
we collect and voxelwisely label a new abdominal CT dataset containing 376 cases
with both arterial and venous phases available for each case, in which 228 cases were
diagnosed with PNETs while the remaining 148 cases are normal, which is currently
the largest dataset for PNETs to the best of our knowledge. In order to incorporate
rich knowledge of radiologists to our framework, we annotate dilated pancreatic duct
as well, which is regarded as the sign of high risk for pancreatic cancer. Quantitatively,
our approach outperforms state-of-the-art segmentation networks and achieves a
sensitivity of 89.47% at a specificity of 81.08%, which indicates a potential direction
to achieve a clinical impact related to cancer diagnosis by earlier tumor detection.
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5.1 Introduction
The American Cancer Society estimates that about 56,770 people in the United States
will be diagnosed with pancreatic cancer in 2019, and that 45,750 will die from the
disease [103]. The oncology community has expended arsenal at this disease with little
effect: the 5-year survival rate remains at only ≈ 5% [22] despite decades of effort.
This is due to the fact that most patients with localized disease have no recognizable
symptoms or signs; as a result, upon diagnosis, tumors have generally spread to critical
abdominal vessels and/or adjacent organs, which is too late to be cured. Despite the
grim statistics, there is still real hope for the early detection, which can boost the 5-year
survival rate by 3 times to reach around 20% given an early diagnosis [23]. Among
pancreatic cancers, the pancreatic adenocarcinoma (PDAC) is the most common type
of pancreatic cancer. Recently, there is a study [20] showing that they can achieve
an overall sensitivity of 94.1% at a specificity of 98.5% for the detection of PDAC,
which sheds light on the possibility of early pancreatic cancer detection. In our work,
we focus on the early detection of pancreatic neuroendocrine tumors (PNETs) from
CT scans, which is harder than the detection of PDAC considering PNETs are less
common with even smaller voxel size.
The detection of PNETs falls into the area of computer aided diagnosis. The
main challenges are lying in three folds: 1) the small size of tumors with respect to
the whole volume; 2) the large tumor variations in location, shape and size across
different patients; 3) the abnormalities can change the texture of surrounding tissues
a lot, which makes the task even harder to locate the tumor targets. With the
unprecedented development of deep learning, in particularly fully convolutional neural
networks (FCNs), there are works which has been driving the field forward in image
segmentation [11], [26], [36]. In the pancreas segmentation area, researchers have been
actively pushing the boundaries of obtaining accurate segmentation performance on
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both normal pancreas [29], [35] and abnormal pancreas [38], [88].
Valuable insights from radiologists’ clinical diagnosis and analysis process can be
leveraged to tackle this problem. First, radiologists are very sensitive to the dilated
pancreatic duct when reading CT scans. There are often occasions the pancreatic duct
is visible to be dilated though the PNETs are barely visible from CT appearance and
texture. Second, the appearance and texture cues can be very different for PNETs
between the venous and arterial phases of CT scans. Radiologists make diagnosis
decision by checking both phases in case the PNETs are hardly to be picked up in one
phase. Missing true PNETs can cause critical areas to remain untreated. To migrate
the aforementioned practical knowledge from radiologists routine works to our system,
on the one hand, we annotated the voxels of dilated pancreatic duct as strong auxiliary
cues to indicate the present of pancreatic cancer. On the other hand, we conduct
PNETs segmentation and classification on both arterial and venous phases to reduce
the missing detection of PNETs. This is done quite different from the state-of-the-art
work on PDACs [20], where they only study on one phase and no cues are explored
from the dilated pancreatic duct. Our final goal is aimed to detect PNETs from a
mixed set of normal and abnormal CT scans. It is not a simple binary classification
task because radiologists want to know the location of tumors, so we use the idea of
Segmentation-for-Classification (S4C), which trains segmentation models and uses
voxel predictions for the classification.
Our contributions are three folds: 1) we voxelwisely label a dual-phase PNETs
dataset in both arterial and venous phases, which is the largest dataset and study
up-to-date to the best of our knowledge; 2) we are the first work of segmentation
and classification for PNETs, where the segmentation makes the classification task
interpretable and extra cues from the dilated pancreatic duct are incorporated in
proposed framework; 3) our overall framework achieves a sensitivity of 89.47% at a
specificity of 81.08%, which indicates the potential direction to a clinical impact.
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5.2 Method
5.2.1 The Overall Framework
We denote the dataset as D = {(X1, y1) , . . . , (XN , yN)}, where N is total number of
CT cases, Xn ∈ RWn×Hn×Ln is a 3D volume with each voxel defined as the Hounsfield
Unit (HU), and yn ∈ {0, 1} is the case label, by which 0 means a normal case while
1 for an abnormal case. By abnormal/tumor we mean cases diagnosed with PNETs
throughout the whole paper. Our goal is to design a model M : y = f(X) mapping a
CT image to its state of being abnormal or not.
Some previous work suggested to classify medical images by directly using deep
neural networks [101], [102], however, we claim that a better strategy is to perform
tumor segmentation together with the classification task. This makes the prediction
interpretable for the classification results from segmentation cues, by which radiolo-
gists can take a further investigation of the suspicious abnormal regions. But for a
deep neural network doing direct classification, it is hard for radiologists to further
check which regions are suspicious while the adopted segmentation-for-classification
(S4C) [20] sheds light on the abnormality detection, which is more plausible. In addi-
tion, this harnesses voxelwise annotations as fully supervision into the classification
model, so that the entire network can be better optimized. Different from [20] which
did S4C for PDAC only on venous phase, we incorporate the dilated pancreatic duct
information on both arterial and venous phases for PNETs, which can further improve
the sensitivity.
On our dataset, each training case is associated with a segmentation mask Mn
of the same dimension as Xn, among which mn,i ∈ {0, 1, 2, 3} denotes the annotated
categories for the i-th voxel. More specifically, a background voxel is labelled as 0, and
1 means the voxel is inside the normal pancreas regions, and 2 denotes a voxel inside
the tumor regions. We would like to emphasize that besides normal/abnormal pancreas
55
Co
nv
1a
, 3
2,
 3
 x 
3 
x 3
Co
nv
2a
, 6
4,
 3
 x 
3 
x 3
Po
ol
in
g 
1,
 m
ax
, 2
Co
nv
2b
, 6
4,
 3
 x 
3 
x 3
Po
ol
in
g 
2,
 m
ax
, 2
Co
nv
3a
, 1
28
, 3
 x 
3 
x 3
Co
nv
3b
, 1
28
, 3
 x 
3 
x 3
Po
ol
in
g 
3,
 m
ax
, 2
Co
nv
4a
, 2
56
, 3
 x 
3 
x 3
Co
nv
4b
, 2
56
, 3
 x 
3 
x 3
Re
s/
Co
nv
3a
, 1
28
, 3
 x 
3 
x 3
De
Co
nv
3a
, 1
28
, 4
 x 
4 
x 4
Re
s/
Co
nv
3b
, 1
28
, 3
 x 
3 
x 3
De
Co
nv
2a
, 6
4,
 4
 x 
4 
x 4
Re
s/
Co
nv
2a
, 6
4,
 3
 x 
3 
x 3
Re
s/
Co
nv
2b
, 6
4,
 3
 x 
3 
x 3
De
Co
nv
1a
, 3
2,
 4
 x 
4 
x 4
Re
s/
Co
nv
1a
, 3
2,
 3
 x 
3 
x 3
Re
s/
Co
nv
1b
, 3
2,
 3
 x 
3 
x 3
In
pu
t
Auxiliary	Loss	#1 Main	LossAuxiliary	Loss	#2
Figure 5.1. The network backbone of our S4C pipeline. We adopt an encoder-decoder
fashion, where the encoder path on the left acts as a feature extractor to learn more and
more compact features while the decoder path on the right decompresses the learned
features gradually to obtain the dense predictions with higher and higher resolutions. The
sum residual connections from the low-level layers are crucial to integrate the pixel-level
features such as edges to the semantically meaningful features of high-level layers such
as patterns or shapes. The two auxiliary losses serve as a deep supervision to reach a
better optimization process, which favors the final segmentation performance [38]. The
whole network is optimized with voxelwise softmax cross-entropy loss. The weight ratio
for auxiliary losses #1, #2 and the main loss is 1 : 2 : 5. Best viewed in color.
regions and background voxels, we annotate voxels inside dilated pancreatic duct
regions as 3. This is motivated from the knowledge of radiologists that a pancreatic
duct dilation is a sign of high risk for pancreatic cancer. If we predict a dilated
pancreatic duct present for some cases where the PNETs are hardly invisible from
textures, we can refine our judgment and would not miss those really hard cases.
Note that a pancreas set includes the normal pancreas set, abnormal pancreas set
and the dilated pancreatic duct set. The segmentation module is a mapping function
M = s(X), which is implemented by an encoder-decoder network mapping from CT
scans with Hounsfield scale values to the categorical sets. The classification module is
a binary function y = c(M) with a set of rules given the segmentation as input that
we will elaborate later. All in all, the whole framework is denoted as:
y = f(X) = c ◦ s(X). (5.1)
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5.2.2 Segmentation for Classification
Our segmentation backbone is shown in Fig. 5.1, which adopts the encoder and
decoder [36] fashion for the dense prediction. The residual connections and auxiliary
losses are the delicate designs aimed at a better and stable optimization [38]. The
pooling layers of the encoder path compress the learning process into more compact
feature space, from where the DeConv layers of the decoder path decompress them to
semantically meaningful features in the fine-scale resolution. The whole framework
takes the voxelwise softmax cross-entropy as the loss function, which shows stable and
supreme performance on both normal pancreas and cystic pancreas segmentation [38].
The segmentation network takes patches as input, whose size is set to be 64×64×64,
which covers sufficient context and makes memory for the networks design with
powerful representation ability.
During training, we implemented simple yet effective augmentations on patches
input, i.e., rotation (90°, 180°, and 270°) and flip in all three axes (axial, sagittal and
coronal), to increase the number of training samples which can alleviate the limited
number of CT cases with annotations. During testing, we adopted the sliding window
way to slide the whole CT volumes with a 20-voxel spatial stride. The overlapped
regions are voted by majority. Based on the segmentation prediction, we classify each
volume to be abnormal or normal. We compute the maximal connected component
Cmax and keep a component which is either larger than 20% of Cmax or at a distance
of less than 27 voxels to Cmax. As for classification, a volume is predicted as PNETs
if as least 40 voxels are predicted as tumors or 500 voxels are predicted as dilated
pancreatic duct. To harness the dual-phase information, we classify a CT case as
abnormal given any phase is predicted as PNETs, which improves the sensitivity at
the cost of the specificity.
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Figure 5.2. The classification network designed for the direct binary classification, i.e.,
tumor versus non-tumor, as an ablation study. Best viewed in color.
5.2.3 Classification Network as Comparison
Since we adopt the Segmentation-for-Classification framework as our pipeline, it is
natural to see how a classification network performs in comparison. Therefore, we
implement a classification network as shown in Fig 5.2. To compare the S4C and
classification network as fair as possible, we construct the classification network by
feeding the features maps of segmentation network as input. This is due to the fact that
the classification label is 0/1 per CT case, which owns much less information than the
voxelwise 0/1’s of segmentation labels. To filter out the large out-of-pancreas regions
during training the classification network, an 128-way feature vector is extracted from
the Region-of-Interest (RoI) of pancreas, which is derived from the ground-truth in
the training or from the segmentation prediction with a margin in the testing. The
128-dimension Pool3 feature is chosen rather than the 256-dimension Conv4b feature
vectors because of the better generalization ability we observed during our experiments.
Since the feature map size is different for different size of pancreas RoIs, the batch
size is chosen to be 1, then a GroupNorm [104] is added after each convolution in the
classification to help the learning process. Note that the segmentation of pancreas is
very good, which makes it doable for the RoI as input.
58
5.3 Experiments
5.3.1 Implementation Details
We collected a new dataset with 376 cases in total from potential renal donors, in
which we have 148 normal cases and 228 biopsy-proven PNETs cases, where each case
has both arterial and venous phases available. Four experts in abdominal anatomy
voxelwisely annotated the pancreas, tumor regions, and dilated pancreatic duct using
the Varian Velocity software, and checked by an experienced board-certified abdominal
radiologist. For a radiologist expert, an average normal case took 20 minutes, and an
average abnormal case 40 minutes to finish the voxelwise annotation. To quantitatively
analyze our method, we adopt a same 4-fold cross-validation for S4C and classification
network on these 376 cases in both phases. All in all, for a single phase, each training
set contains 111 normal and 171 abnormal cases, and each corresponding testing set
contains 57 abnormal and 37 normal cases. And the final quantitative performance is
reported on the testing of all cases across 4 folds, by which we take every case into
consideration to fully maximize the utilization of the medical data which are expensive
and time-consuming to obtain. Our framework is implemented on Pytorch 0.5.0, and
the GPU we are running on is the Tesla V100. The base learning rate is 0.01 and
decayed polynomially (the power is 0.9) in a total of 80,000 iterations with a batch
size of 16 for the S4C. The base learning rate is 0.001 and decayed polynomially (the
power is 0.9) in a total of 20,000 iterations for the classification network. The weight
decay and momentum are set to be 0.0005 and 0.9, separately. The total training
time for a S4C model is 2.5 days while the average testing time for a case is around 10
mins while the training time for a classification is ≈ 12 mins given the segmentation
features as input. All parameters are verified by the 4-fold cross-validation.
One of our goals is to quantify the segmentation accuracy by the Dice-Sørensen
Coefficient (DSC) between the predicted and the ground-truth tumor regions Y and
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Y⋆, i.e., DSC(Y , Y⋆) = 2×|Y∩Y
⋆|
|Y|+|Y⋆| . Our primary goal is to measure the abnormality
classification by the sensitivity (the percentage of correctly classified abnormal cases)
and the specificity (the percentage of correctly classified normal cases). In practice,
there is always a trade-off between the sensitivity and specificity. We care much more
about the sensitivity than the specificity since the final goal is to detect PNETs in the
early stage for timely medical interventions.
5.3.2 Performance
From Table 5.1 that shows single-phase results, considering venous and arterial
phases equally, our method in the venous phase achieves the best results on all
evaluation matrix except for the comparable result with 3D UNet on the venous
normal pancreas segmentation. On the one hand, the pancreas segmentation can
be as high as 87.41% and 84.69% for the normal pancreas and abnormal pancreas
respectively, which demonstrates the effectiveness of our method. On the other hand,
the tumor segmentation performance is promising to be 43.11%, which outperforms
the state-of-the-art segmentation networks, i.e., 3D UNet [10] and VNet [11]. From the
tumor segmentation results, it is a really challenging segmentation problem considering
the various size, shape and locations of tumors. Note that a recent work on the PDAC
segmentation achieves a DSC of 56.46 ± 26.23% [20], which is not as hard as the
PNETs which are less common with even smaller voxel size. As for the abnormality
classification task, our single phase model achieves 82.46% sensitivity at a specificity
of 91.89%, which beats the second best 3D UNet by 0.88% and 2.70% respectively. To
compare the same model in arterial and venous phases, we find that all three models
behave generally better on the venous phase than the arterial phase. As in Fig. 5.3,
our method performs better segmentation results for both venous and arterial phases,
which shows the more powerful representation ability of our network backbone.
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Venous Label Ours UNet VNet Arterial Label Ours UNet VNet
Figure 5.3. The segmentation visualization for the case number 7263. “Ours” method
successfully detects the PNETs and dilated pancreatic duct regions on both the venous
and the arterial phase, which performs better then “3D UNet” and “VNet”.
Venous CT Label Ours Arterial CT Label Ours
Figure 5.4. The segmentation visualization for the case number 7264. The tiny PNETs
is hanging of the pancreas head, where “Ours” method successfully detects the PNETs
regions on the arterial phase while missing the detection on the venous phase.
5.3.3 Dual-Phase Fusion and Comparison with Classification
Network
In the clinical practice, the radiologists generally care much more about the sensitivity
than they do about the specificity when it comes to the tumor detection. In radiology,
some tissues are more visible in the venous phase while others are better to be captured
in the arterial phase. Given we have CT scans in both arterial and venous phases
available for each case, it is natural to think that we can combine the detection results
from two phases together to take advantage of the different enhancement patterns
when detecting the abnormality from different phases. We come up with a very
straightforward way to combine the detection results. More specifically, if a model
trained on any phase predicts this case to be abnormal, we regard this case to be
abnormal. In this way, we are able to reduce the missing cases since a PNETs case
can only be missed if both two phases classify the same case to be normal. The
quantitative results are given in Table 5.2. First, our model beats both 3D UNet and
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Phase Method N.Pan A.Pan Tumor Misses W.Calls Sen Spe
Venous Ours 87.41% 84.69% 43.11% 40/228 12/148 82.46% 91.89%
Venous UNet 87.70% 83.84% 41.43% 42/228 16/148 81.58% 89.19%
Venous VNet 86.76% 83.90% 40.67% 49/228 20/148 78.51% 86.49%
Arterial Ours 81.78% 83.34% 42.49% 44/228 21/148 80.70% 85.81%
Arterial UNet 82.47% 83.33% 42.58% 44/228 20/148 80.70% 86.49%
Arterial VNet 83.85% 82.79% 39.22% 43/228 31/148 81.14% 79.05%
Table 5.1. Performance of segmentation and classification on our own dataset in two
different phases. From left to right: normal pancreas cases, abnormal pancreas cases and
tumor segmentation accuracy (DSC, %), the number of missed abnormal cases out of 228
abnormal cases in total, the number of wrong calls of tumor predictions out of 148 normal
cases in total, the corresponding sensitivity and the specificity.
VNet after the fusion as well. Second, in the trade-off by fuse two phases, we increase
the sensitivity by 7.01% at the cost of the specificity drop by 10.81%, by which we
value the fusion when it comes to the possible critical point of life or death for patients.
As in Fig. 5.4, we visualize one case where our method misses the tumor prediction in
the venous phase while detecting the tiny tumors successfully in the arterial phase.
From Table 5.2, S4C achieves the best in the sensitivity, which verifies the effec-
tiveness of S4C framework. For the lower specific city of S4C than the classification
network, we conjecture that the classification network is trained directly with a binary
optimization goal and the feature map of segmentation as input can be favorable to
classification network. However, the major drawback of the classification network
is that it is notoriously hard to identify which regions in the original CT scans con-
tribute to the final abnormality prediction. But, for our S4C framework, we provide
radiologists with the predicted abnormal regions as a crucial cue for why we reach the
decision. The convenience brought to radiologists for further diagnosis can be valued
even with slightly lower specificity.
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Phase Method Misses W.Calls Sensitivity Specificity.
Arterial&Venous S4C (Ours) 24/228 28/148 89.47% 81.08%
Arterial&Venous 3D UNet 26/228 31/148 88.60% 79.05%
Arterial&Venous VNet 28/228 37/148 87.72% 75.00%
Arterial&Venous Classification 24/228 23/148 89.47% 84.46%
Table 5.2. Performance of abnormality classification on our own dataset by considering
two phases together. From left to right: the number of missed abnormal cases out of 228
abnormal cases in total, the number of wrong calls of tumor predictions out of 148 normal
cases in total, the corresponding sensitivity and the specificity.
5.4 Conclusion and Future Works
In this work, we propose an overall framework to conduct the early detection of
PNETs, the second common type of pancreatic cancer. We adopt the Segmentation-
for-Classification strategy to make the classification result more interpretable to
radiologists compared with a direct binary classification network. To quantitatively
analyze our method, we voxelwisely annotate the largest PNETs CT dataset to the
best of our knowledge. Furthermore, each CT case is collected in both arterial and
venous phase, where the voxels of dilated pancreatic duct are annotated as well to
increase the sensitivity in practice. Our approach outperforms the state-of-the-arts
segmentation algorithms in terms of the DSC score and is comparable to a binary
classification neural network in terms of sensitivity and specificity. In the future, we
would like to integrate the classification network into the segmentation backbone,
which can let these two tasks benefit from each other by a joint learning manner.
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Chapter 6
V-NAS: Neural Architecture
Search for Volumetric Medical
Image Segmentation
Deep learning algorithms, in particular 2D and 3D fully convolutional neural networks
(FCNs), have rapidly become the mainstream methodology for volumetric medical
image segmentation. However, 2D convolutions cannot fully leverage the rich spatial
information along the third axis, while 3D convolutions suffer from the demanding
computation and high GPU memory consumption. In this paper, we propose to
automatically search the network architecture tailoring to volumetric medical image
segmentation problem. Concretely, we formulate the structure learning as differ-
entiable neural architecture search, and let the network itself choose between
2D, 3D or Pseudo-3D (P3D) convolutions at each layer. We evaluate our method
on 3 public datasets, i.e., the NIH Pancreas dataset, the Lung and Pancreas dataset
from the Medical Segmentation Decathlon (MSD) Challenge. Our method, named
V-NAS, consistently outperforms other state-of-the-arts on the segmentation tasks
of both normal organ (NIH Pancreas) and abnormal organs (MSD Lung tumors and
MSD Pancreas tumors), which shows the power of chosen architecture. Moreover, the
searched architecture on one dataset can be well generalized to other datasets, which
demonstrates the robustness and practical use of our proposed method.
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6.1 Introduction
Over the past few decades, medical imaging techniques, e.g., magnetic resonance
imaging (MRI), computed tomography (CT), have been widely used to improve the
state of preventative and precision medicine. With the emerging of deep learning,
great advancement has been made for medical image analysis in various applications,
e.g., image classification, object detection, segmentation and other tasks. Among
these tasks, organ segmentation is the most common area of applying deep learning
to medical imaging [14].
In this work, we focus on the volumetric medical image segmentation. Taking the
pancreas and lung tumors segmentation from CT scans as an example as shown in
Fig. 6.1, the main challenges lie in several aspects: 1) the small size of organs with
respect to the whole volume; 2) the large variations in location, shape and appearance
across different cases; 3) the abnormalities, i.e., the pancreas and lung tumors, can
change the texture of surrounding tissues a lot; 4) the anisotropic property along
z-axis, which make the automatic segmentation even harder.
To tackle these challenges, many segmentation methods have been proposed in
the literature. Starting from handcrafted features, there are methods proposed to use
intensity thresholding [57], region growing [56], and deformable models [58], which
often suffer from the limited feature representation ability and are less invariant to
the large organ variations. With a huge influx of deep learning related methods, fully
convolutional neural networks (FCNs), e.g., 2D and 3D FCNs, have become the main-
stream methodology in the segmentation area by delivering powerful representation
ability and good invariant properties. The 2D FCNs based methods [18], [29], [30],
[35], [36] perform the segmentation slice-by-slice from different views, then fuse 2D
segmentation output to obtain a 3D result, which is a remedy against the ignorance
of the rich spatial information. To make full use of the 3D context, 3D FCNs based
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Image Label Image Label
NIH
Pancreas
MSD 
Lung
MSD 
Pancreas
Figure 6.1. Typical examples from NIH Pancreas [18] in the 1st row, MSD Lung
Tumors [19] in the 2nd row and MSD Pancreas Tumors [19] in the 3rd row. Two slices
of different cases are randomly chosen from each dataset. Normal Pancreas regions are
masked as blue and abnormal pancreas regions are masked as red. The lung cancers are
masked as blue. Best viewed in color.
methods [10], [11], [37], [38] directly perform the volumetric prediction. However, the
demanding computation and high GPU consumption of 3D convolutions limit the
depth of neural networks and input volume size, which impedes the massive application
of 3D convolutions. Recently, the Pseudo-3D (P3D) [39] was introduced to replace 3D
convolution k×k×k with two convolutions, i.e., k×k×1 followed by 1×1×k, which
can reduce the number of parameters and show good learning ability in [40], [41] on
anisotropic medical images. However, all the aforementioned existing works choose the
network structure empirically, which often impose explicit constraints, i.e., either 2D,
3D or P3D convolutions only, or 2D and 3D convolutions are separate from each other.
These hand-designed segmentation networks with architecture constraints might not
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be the optimal solution considering either the ignorance of the rich spatial information
for 2D or the demanding computations for 3D.
Drawing inspiration from recent success of Neural Architecture Search (NAS),
we take one step further to let the segmentation network automatically choose
between 2D, 3D, or P3D convolutions at each layer by formulating the structure
learning as differentiable neural architecture search [42], [43]. To the best of
our knowledge, we are one of the first to explore the idea of NAS/AutoML in medical
imaging field. Previous work [44] used reinforcement learning and the search restricts
to 2D based methods, whereas we use differentiable NAS and search between 2D, 3D
and P3D, which is more effective and efficient. Without pretraining, our searched
architecture, named V-NAS, outperforms other state-of-the-arts on segmentation of
normal pancreas, the abnormal lung tumors and pancreatic tumors. In addition, the
searched architecture on one dataset can be well generalized to others, which shows
the robustness and potential clinical use of our approach.
6.2 Related Work
6.2.1 Medical Image Segmentation
The volumetric medical image segmentation has been dominated by deep convolutional
neural networks based methods in recent years. [36] proposed the UNet architecture
tailored to tackle medical image analysis problems in 2D, which is based on an
encoder-decoder framework: the encoder is designed to learn higher and higher level
representations while the decoder decompresses compact features into finer and finer
resolution to obtain dense prediction. Then, a similar approach was presented by [10]
to extend UNet to 3D input. Later on, VNet [11] proposed to incorporate residual
blocks penalized by the Dice loss rather than the cross-entropy loss on 3D data, which
directly minimizes the used segmentation error measurement. Meanwhile, a few recent
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works have been proposed to combine 2D and 3D FCNs as a compromise to leverage
the advantages of both sides. [64] adopted a 3D FCN by feeding the segmentation
predictions of 2D FCNs as input together with 3D images. H-DenseUNet [65] hy-
bridized a 2D DenseUNet for extracting intra-slice features and a 3D counterpart for
aggregating inter-slice contexts. Similarly, 2D FCNs and 3D FCNs are not optimized
at the same time in [64], [65].
6.2.2 Neural Architecture Search
Neural Architecture Search (NAS) is the process of automatically discovering better
neural architectures than human designs. We summarize the progress in along two
dimensions: search algorithm and dataset/task.
Many NAS algorithms belong to either reinforcement learning or evolutionary
algorithm. In the reinforcement learning formulation [67], the actions generated by
an agent define the network architecture, and the reward is the accuracy on the
validation set. In the evolutionary formulation [68], architectures are mutated to
produce better offsprings, again measured by validation accuracy. Although these
algorithms are general, they are usually computationally costly. To address this
problem, [69] progressively expand the search space in order to achieve better sample
efficiency. Differentiable NAS approaches [42], [43], [70] utilize sharing among candidate
architectures, and are arguably the most efficient family of algorithms to date.
At the same time, we also notice that the earlier papers [71]–[73] focused solely
on MNIST or CIFAR10 dataset. Later, [67]–[69] searched for “transferable archi-
tectures” from the smaller CIFAR10 to the much larger ImageNet dataset. More
recently, [74], [75] demonstrated the possibility to directly search for architectures
on the ImageNet dataset. Finally, [42] extended NAS beyond image classification to
semantic segmentation.
This paper sits at the frontier of both dimensions discussed above. We follow the
68
differentiable NAS formulation for its efficiency. In terms of application domain, we
directly search on volumetric image segmentation data, which is more demanding and
challenging than 2D image labeling.
6.3 Method
We define a cell to be a fully convolutional module, typically composed of several
convolutional (Conv+BN+ReLU) layers, which is then repeated multiple times to
construct the entire neural network. Our segmentation network follows the encoder-
decoder [11], [36] structure while the architecture for each cell, i.e., 2D, 3D, or P3D, is
learned in a differentiable way [42], [43]. The whole network structure is illustrated in
Fig. 6.2, where green Encoder and blue Decoder are in the search space. We start with
depicting the detailed network structure in Sec. 6.3.1, and then describing the search
space of green Encoder and blue Decoder in Sec. 6.3.2 and Sec. 6.3.3, respectively,
followed by the optimization and search process in Sec. 6.3.4.
6.3.1 Basic Network Architecture
As shown in the upper part of Fig. 6.2, our task is to train a convolution neural
network model to predict the voxel labels of a CT scan as input. Similar to the
state-of-the-art segmentation networks U-Net [36], V-Net [11], 3D U-Net [10] and
ResDSN [38], our overall network structure consists of a high-to-low resolution process
as a feature extractor, and then recovers the resolution through a low-to-high process
to obtain dense predictions. To downsample 3D feature maps from a high resolution
to a low resolution, the “Conv-Max Pool Down” in the encoder path is implemented
by a conv kernel of 1×1×1 with a stride of [2, 2, 1] followed by a MaxPool 1×1×2 with
a stride of [1, 1, 2]. The counterpart along the decoder path is realized by the “Up”
module to upsample 3D feature maps from a low resolution to a high resolution. More
specifically, the “Up” layer first projects the input feature map to match the number
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Figure 6.2. The segmentation network architecture. Each Encoder cell and Decoder
cell has two candidate conv layers X and Y which are chosen between 2D, 3D, or P3D,
whose details are defined in Sec. 6.3.2 and Sec. 6.3.3. The Encoder along the encoding
path is repeated by 3, 4, 6, 3 times while the decoder circled in the dashed rectangle is
repeated by 3 times. The encoder path is designed from ResNet-50, while the decoder
path takes advantage of dense block and pyramid volumetric pooling (PVP). The first two
convolutional layers adopt a kernel size 7×7×1 with stride [2, 2, 1] and 1×1×3 with stride
[1, 1, 1]. The overall network architecture is effectively verified by [40] while we add the
searching process for color blocks to choose between 2D, 3D, and P3D.
of feature channels of the higher Encoder feature by a 1×1×1 conv, followed by the
3D tri-linear interpolation and element-wise sum with the Encoder feature at a higher
resolution. The residual connections from the lower-level encoder to the higher-level
decoder aggregate more detailed information to semantic meaningful feature maps
to give more accurate dense predictions. A pyramid volumetric pooling module [105]
is stacked at the end of the decoder path before the final output layer for fusing
multiscale features.
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6.3.2 Encoder Search Space
The set of possible Encoder architecture is denoted as E , which includes the following
3 choices (c.f., Fig.6.2 for Encoder
[︄
X
Y
]︄
):
{Encoder
[︄
3 × 3 × 1
1 × 1 × 1
]︄
⏞ ⏟⏟ ⏞
E0: 2D
, Encoder
[︄
3 × 3 × 3
1 × 1 × 1
]︄
⏞ ⏟⏟ ⏞
E1: 3D
, Encoder
[︄
3 × 3 × 1
1 × 1 × 3
]︄
⏞ ⏟⏟ ⏞
E2: P3D
} (6.1)
As shown in Eq. 6.1, we define 3 Encoder cells, consisting of the 2D Encoder
E0, 3D Encoder E1, and P3D Encoder E2. 3×3×1 is considered as 2D kernel. The
input of the l-th cell is denoted as xl while the output as xl+1, which is the input of
the (l + 1)-th cell. Conventionally, the encoder operation Ole ∈ E in the l-th cell is
chosen from one of the 3 cells, i.e., either E0, E1, or E2. To make the search space
continuous, we relax the categorical choice of a particular Encoder cell operation Ole as
a softmax over all 3 Encoder convolution cells. By Eq. 6.2, the relaxed weight choice
is parameterized by the encoder architecture parameter α, where αli determines the
probability of encoder Ei in the l-th cell,
xl+1 = Ole(xl) ≈ Ō
l
e(xl)
Ō
l
e(xl) =
∑︂2
i=0
exp(αli)∑︁2
j=0 exp(αlj)
Ei(xl),
(6.2)
where l = 1, . . . , L.
6.3.3 Decoder Search Space
Similarly, the set of possible Decoder architectures is denoted as D, consisting of the
following 3 choices (c.f., Fig. 6.2 for Decoder
[︄
X
Y
]︄
):
{Decoder
[︄
3 × 3 × 1
3 × 3 × 1
]︄
⏞ ⏟⏟ ⏞
D0: 2D
, Decoder
[︄
3 × 3 × 3
3 × 3 × 3
]︄
⏞ ⏟⏟ ⏞
D1: 3D
, Decoder
[︄
3 × 3 × 1
1 × 1 × 3
]︄
⏞ ⏟⏟ ⏞
D2: P3D
} (6.3)
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As given in Eq. 6.3, we define 3 Decoder cells, composed of the 2D Decoder D0, 3D
Decoder D1, and P3D Decoder D2. The Decoder cell is defined as dense blocks, which
shows powerful representation ability in [40], [65]. The input of the b-th Decoder cell
is denoted as xb while the output as xb+1, which is the input of the (b + 1)-th Decoder
cell. The decoder operation Obd of the b-th block is chosen from either D0, D1, or
D2. As shown in Eq. 6.4, we also relax the categorical choice of a particular decoder
operation Obd as a softmax over all 3 Decoder convolution cells, parameterized by the
decoder architecture parameter β, where βbi is the choice probability of decoder Di in
the b-th dense block,
xb+1 = Obd(xb) ≈ Ō
b
d(xb)
Ō
b
d(xb) =
∑︂2
i=0
exp(βbi )∑︁2
j=0 exp(βbj)
Di(xb),
(6.4)
where b = 1, . . . , B.
6.3.4 Optimization
After relaxation, our goal is to jointly learn the architecture parameters α, β and the
network weights w by the mixed operations. The introduced relaxations in Eq. 6.2
and Eq. 6.4 make it possible to design a differentiable learning process optimized by
the first-order approximation as in [43]. The algorithm for searching the network
architecture parameters is given in Alg. 1. After obtaining optimal encoder and decoder
operations Ole and Obd by discretizing the mixed relaxations Ō
l
e and Ō
b
d through argmax,
we retrain the searched optimal network architectures on the Strainval = {Strain, Sval}
and then test it on Stest.
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Algorithm 1: V-NAS
Partition the whole labeled dataset S into the disjoint Strain, Sval and Stest;
Create the mixed operations Ōle and Ō
b
d parametrized by αli and βbi ,
respectively;
while training not converged do
1. Update weights w by descending ∇wLtrain(w,α,β)
2. Update α and β by descending ∇α,βLval(w,α,β)
Replace the relaxed operation Ōle with
Ole = Ei, i = argmaxkexp(αlk)/
∑︁2
j=0 exp(αlj);
Replace the relaxed operation Ōbd with
Obd = Di, i = argmaxkexp(βbk)/
∑︁2
j=0 exp(βbj);
Retrain the discretized architecture on the Strainval.
6.4 Experiments
6.4.1 Implementation Details
In this work, we consider a network architecture with L=3+4+6+3=16 and B=5,
shown as color blocks in Fig. 6.2. The search space contains 3L+B=321≈1010 different
architectures, which is huge and challenging. The architecture search optimization is
conducted for a total of 40,000 iterations. When learning network weights w, we adopt
the SGD optimizer with a base learning rate of 0.05 with polynomial decay (the power
is 0.9), a 0.9 momentum and weight decay of 0.0005. When learning the architecture
parameters α and β, we use Adam optimizer with a learning rate of 0.0003 and weight
decay 0.001. Instead of optimizing α and β from the beginning when weights w are
not well-trained, we start updating them after 20 epochs. After the architecture search
is done, we retrain weights w of the optimal architecture from scratch for a total of
40,000 iterations. The searching process takes around 1.2 V100 GPU days for one
partition of train, val and test. All our models are trained on one V100 GPU with a
customized batch size tuned to take full usage of the GPU memory due to different
size input, which is computationally efficient in terms of neural architecture search
task brought by the patch input.
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In order to evaluate our method in the 4-fold cross-validation manner to fairly
compare with existing works, we randomly divide a dataset into 4 folds, where each
fold is evaluated once as the Stest while the remaining 3 folds as the Strain and Sval
with a train v.s. val ratio as 2 : 1. Therefore, there are in total 4 architecture search
processes considering the 4 different {Strain, Sval}. The searched architecture might
be different for each fold due to different {Strain, Sval}. In this situation, the ultimate
architecture is obtained by summing the choice probabilities (α and β) across the 4
search processes and then discretize the aggregated probabilities. Finally, we retrain
the optimal architecture on each Strainval and evaluate on the corresponding Stest.
All our implemented experiments use the same split of cross-validation and adopt
Cross-Entropy loss, evaluated by the Dice-Sørensen Coefficient (DSC) formulated as
DSC(P , Y) = 2×|P∩Y||P|+|Y| , where P and Y denote for the prediction and ground-truth
voxels set for a foreground class, respectively. This evaluation measurement ranges
in [0, 1] where 1 means a perfect prediction. We conduct experiments on 3 public
datasets, i.e., the NIH Pancreas dataset, the Pancreas and Lung dataset from the
Medical Segmentation Decathlon (MSD) Challenge. And ablation studies are done on
the NIH Pancreas dataset.
6.4.2 NIH Pancreas Dataset
We conduct experiments on the NIH pancreas segmentation dataset [18], which
contains 82 normal abdominal CT volumes. The size of CT volumes is 512 × 512 × D,
where the number of slices D is different for different cases, ranging in [181, 466].
The physical spatial resolution for one voxel is w × h × d, where d = 1.0mm and
w = h that ranges from 0.5mm to 1.0mm. For the data pre-processing, we simply
truncate the raw Hounsfield Unit (HU) values to be in [−100, 240] and then normalize
each raw CT case to have zero mean and unit variance to decrease the data variance
caused by the physical processes [98] of medical images. As for the data augmentation
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Method Categorization Mean DSC Max DSC Min DSC
V-NAS (Ours) Search 85.15± 4.55% 91.18% 70.37%
Baseline (Ours) Mix 84.36 ± 5.25% 91.29% 67.20%
Xia et al. [64] 2D/3D 84.63 ± 5.07% 91.57% 61.58%
Zhu et al. [38] 3D 84.59 ± 4.86% 91.45% 69.62%
Yu et al. [106] 2D 84.50 ± 4.97% 91.02% 62.81%
Cai et al. [35] 2D 82.40 ± 6.70% 90.10% 60.00%
Zhou et al. [30] 2D 82.37 ± 5.68% 90.85% 62.43%
Dou et al. [37] 3D 82.25 ± 5.91% 90.32% 62.53%
Roth et al. [29] 2D 78.01 ± 8.20% 88.65% 34.11%
Roth et al. [18] 2D 71.42 ± 10.11% 86.29% 23.99%
Table 6.1. Comparison with other state-of-the-arts on the NIH Pancreas dataset evaluated
by the 4-fold cross validation. Our one-stage segmentation network outperforms two-stage
coarse-to-fine state-of-the-arts [38], [64]. The “Categorization” column categorizes each
method by whether the segmentation method is based on 2D, 3D, or by the dynamic
searching in our proposed method. The architecture searched on the NIH Pancreas dataset
is coded as [0 0 0, 0 0 0 1, 2 0 2 0 2 2, 0 0 0] for the 16 Encoder cells, and [0 0 1 0 1] for
the 5 Decoder blocks.
in the training phase, we adopt simple yet effective augmentations on all training
patches, i.e., rotation (90°, 180°, and 270°) and flip in all three axes (axial, sagittal
and coronal), to increase the number of 3D training examples which can alleviate
the scarce of CT scans with expensive human annotations. Our training and testing
procedure take patches as input to make more memory for the architecture design,
where the training patch size is 96×96×64 and the testing patch size is 64×64×64 for
the fine scale testing.
As shown in Table 6.1, our searched optimal architecture outperforms recent
state-of-the-arts [38], [64], [106] segmentation algorithms. It is well worth noting
that state-of-the-arts [38], [64] adopt a two-stage coarse-to-fine framework to have
an extra segmentation network to refine the initial segmentation maps whereas our
method outperforms them by only one stage segmentation, which is more efficient
and effective. We also obtain the smallest standard deviation and the highest Min
DSC, which demonstrates the robustness of our segmentation across all CT cases.
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Furthermore, we implement the “Mix” baseline that equally initializes all architecture
parameters α and β and keep them frozen during the training and testing procedures,
which basically means the output takes exactly equal weight from 2D, 3D, and P3D in
the encoder and decoder paths. Quantitatively, the search mechanism outperforms the
“Mix” baseline by 3.17% and 0.79% in terms of the Min and Mean DSC, respectively,
which verifies the effectiveness of the searching framework.
In details, we code the searched optimal architecture on the NIH Pancreas dataset
by [0 0 0, 0 0 0 1, 2 0 2 0 2 2, 0 0 0] for the 16 Encoder cells, and [0 0 1 0 1] for the
5 Decoder blocks, where “0”, “1” and “2” individually denote for the 2D, 3D and
P3D, which are derived from definitions given in the Eq. 6.1 and Eq. 6.3. We observe
that 2D convolutions are mostly picked up in the beginning for encoders while P3D
appears in the intermediate encoders, and 3D convolutions are mostly chosen in the
ending decoders. We hypothesize that 2D layer is efficient to extract the within-slice
information coupled with the P3D to fuse learned feature maps in the intermediate
stage while 3D kernels are effective in the semantic meaningful layers close to the
output prediction.
We visualize two slices randomly chosen from three NIH pancreas cases as shown
in Fig. 6.3. For the Case “#72” with a DSC of 90.96%, the pancreas appearance
and boundary are well-captured and distinguished from its surroundings. For the
Case “#81” with a DSC close to the “Mean DSC”, the pancreas regions are generally
predicted well though with some minor under-estimations near the head. As for the
Case “#42” with the min DSC, the “VNAS” makes mistakes in the condition where
the surrounding tissues are very complicate and the boundaries are ambiguous.
6.4.3 MSD Lung Tumors
We also evaluate our framework on the Lung Tumors dataset from the Medical
Segmentation Decathlon Challenge (MSD) [19], which contains 64 training and 32
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Image Label VNAS Image Label VNAS
Case #74
DSC 90.96
Case #42
DSC 70.37
Case #81
DSC 85.30
Figure 6.3. The visualization illustration of predicted segmentation for “VNAS” on the
NIH Pancreas dataset. Two slices from Case “#74”, “#42” and “#81” are randomly
selected for visualization. The “Min DSC” Case “#42” and an average DSC Case “#81”
are chosen. Blue masked regions denote for the pancreas voxels. Best viewed in color.
testing CT scans. It is aimed for the segmentation of a small target (lung tumors) in
a large image, where only the lung cancers are labelled and to be segmented. Since
the testing label is not available and the challenge panel is currently closed, we report
and compare results of 4-fold cross-validation on the available 64 training set. The
truncation range is set to be [−1000, 1000] to cover almost all the lung HU values
in the data pre-processing while the data augmentation is the same as mentioned in
Sec. 6.4.2. More specifically, the patch size is set to be 64×64×64 for the training and
testing on MSD Lung Tumors dataset.
As given in Table 6.2, our method (V-NAS-Lung) beats 3D UNet [10] and VNet [11]
by a large margin, at least 2.33% in terms of the “Mean DSC”. The search process
consistently outperforms the “Mix” version which takes equally the 2D, 3D and P3D
as a fixed configuration. It is worth noting that the “Max DSC” of ours falls behind
3D UNet and VNet. We conjecture that since the overall network architecture is
configured by the average choice probabilities of parameters α and β on 4 splits, our
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Method Categorization Mean DSC Max DSC Median
V-NAS-Lung (Ours) Search 55.27± 31.18% 90.32% 66.95%
V-NAS-NIH (Ours) Search 54.01 ± 31.39% 92.17% 68.93%
Baseline (Ours) Mix 52.27 ± 31.40% 89.57% 61.71%
3D UNet 3D 52.94 ± 31.28% 93.58% 61.08%
VNet 3D 50.47 ± 31.37% 93.85% 57.82%
Table 6.2. Performance of different methods on the MSD Lung tumors dataset evaluated
by the same 4-fold cross validation. The searched architecture on Lung tumors is coded as
[0 0 0, 1 2 0 1, 2 1 2 0 0 0, 0 0 0] and [0 0 2 1 1]. It is worth noting that the searched
architecture on the NIH dataset is well generalized to the Lung tumors dataset.
method tends to stably achieve the best overall segmentation performance, which
is consistent with the much higher “Median DSC”. More specifically, the searched
architecture on Lung tumors is coded as [0 0 0, 1 2 0 1, 2 1 2 0 0 0, 0 0 0] and [0 0 2 1
1].
To take one step further, we report results of directly training the searched optimal
architecture from the NIH Pancreas dataset (V-NAS-NIH) on the MSD Lung tumors
dataset from scratch. The searched architecture generalizes well and achieves better
performance than “Mix”, 3D UNet and VNet. By comparing the two searched
architectures from NIH Pancreas and MSD Lung Tumors datasets, we find that the
two optimal architectures V-NAS-Lung and V-NAS-NIH share 68% (11 out of 16
Encoder cells) for the encoder path and 60% (3 out of 5 Decoder blocks) for the
decoder path. The good property of transferring the network architecture searched
on one dataset to another makes it possible for us to train the network architecture
searched on a fairly big dataset with rich annotations to a small dataset with scarce
annotations. We have not shown the “Min DSC” in the table since all approaches
miss some lung tumors considering the lowest DSC to be 0, which shows that small
lung tumors segmentation is a quite challenging task.
78
6.4.4 MSD Pancreas Tumors
Different from the NIH normal pancreas dataset, the MSD Pancreas Tumors dataset
is labeled with both pancreatic tumors and normal pancreas regions. The original
training set contains 282 portal venous phase CT cases, which are randomly split into
4 folds in our experiment, where each fold has its own training, validation and testing
set and the final segmentation performance is reported on the average of 4 folds. Since
the resolution along z-axis of this dataset is very low and number of slices can be
as small as 37, the resolution of all cases on MSD Pancreas Tumors dataset are first
re-sampled to an isotropic volume resolution of d = 1.0mm for each axis. Then the
pre-processing and data augmentation is the same as Sec. 6.4.2. The patch size is set
to be 64 × 64 × 64 for both training and testing phases. Due to variant shapes and
locations of tumors, the tumor segmentation is much more challenging and clinically
important than the normal pancreas segmentation task since the early detection of
pancreatic tumors can save lives.
As shown in Table 6.3, our searched architecture consistently outperforms 3D UNet
and VNet, especially the pancreas tumors DSC delivers an improvement of at least
1.79%, which is regarded as a fairly good advantage. The 7.68% improvement over
the manual “Mix” setting on the pancreas tumors consistently proves the advantage
of the architecture search in the volumetric image segmentation domain. In details,
the searched architecture on this dataset is coded as [0 2 2, 2 0 0 0, 2 2 1 2 1 1, 0 1 1]
and [1 0 2 0 1], by which we observe there are more P3D and 3D convolutions selected
compared with the searched optimal architecture from the NIH normal Pancreas
dataset. We hypothesize that the between-slice information is very important to detect
abnormalities since radiologists need to scroll up and down when reading CT scans to
help the diagnosis.
We illustrate the visualization results of different methods as given in Fig. 6.4 on
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Method Categor. Pancreas Tumors DSC Pancreas DSC
Mean Max Median Mean Max Min
V-NAS (Ours) Search 37.78± 32.12% 92.49% 38.32% 79.94± 8.85% 92.24% 36.99%
Baseline (Ours) Mix 30.10 ± 31.40% 92.95% 18.05% 78.41 ± 9.40% 92.21% 40.08%
3D UNet 3D 35.61 ± 32.20% 93.66% 32.23% 79.20 ± 9.43% 91.95% 40.72%
VNet 3D 35.99 ± 31.27% 92.95% 35.91% 79.01 ± 9.44% 92.05% 28.15%
Table 6.3. Performance of different methods on the MSD Pancreas tumors dataset
evaluated by the same 4-fold cross validation. The results are given on the normal pancreas
regions and pancreatic tumors, respectively. The searched architecture on Pancreas tumors
dataset is coded as [0 2 2, 2 0 0 0, 2 2 1 2 1 1, 0 1 1] and [1 0 2 0 1].
the same slice of a same case for comparison in each row. 4 cases ( #309, #021, #069
and #329) are chosen from the MSD Pancreas dataset, which are shown from top to
bottom at each row, respectively. Note that the masked red and blue regions denote
the pancreas tumor and normal pancreas regions, respectively. For the case #309 in
the first row, the proposed “V-NAS” successfully detects the tiny tumor regions while
“Mix” and “3D UNet” totally fails and “VNet” almost fails by only finding several
tumor pixels. For the case #021, #069 and #329 from the 2nd to the 4th row, the
searched architecture can semantically capture the tumor regions better because it can
adaptively leverage both the rich 3D spatial context, the 2D within-slice information
and the anisotropic structures.
6.4.5 Discussions
To further verify the advantage of automatically selecting among 2D, 3D and P3D
convolution layers via the neural architecture search, we conduct ablation studies on
manually choosing types in encoder and decoder paths to be purely either 2D, 3D or
P3D on NIH Pancreas and MSD Lung Tumors datasets in this section.
6.4.5.1 Manual Setting on NIH Pancreas Dataset
As shown in Table 6.4, we manually configurate the architecture of Encoder and
Decoder, where we train and test all configurations on the same 4-fold cross validation.
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Image Label VNAS Mix 3D UNet VNet
Figure 6.4. The visualization illustration of predicted segmentation for “VNAS”, “Mix”,
“3D UNet” and “VNet” on the MSD Pancreas Tumors dataset, which is the most challenging
task among our 3 segmentation tasks. Each row denotes a slice visualization from one
case, and the specific cases numbers are “309”, “021”, “069” and “329” from top to
bottom rows. The masked blue and red regions denote for the normal pancreas regions
and tumor regions, respectively. Best viewed in color.
More specifically, all Encoders are set to be one type (2D, 3D, or P3D), and the same
strategy is applied to the Decoders. Each row denotes the pure categorical choice for
the Encoder cells while the column for the Decoder. We can find that 2D, 3D, and
P3D kernels contribute differently to the segmentation by the experimental results.
The P3D as Encoder and the P3D as Decoder achieve a mean DSC of 84.75% to
outperform all other manual configurations. It is conjectured that the pure P3D
takes most advantage of the anisotropic data annotation of the NIH dataset, where
the annotation was done slice-by-slice along the z-axis. The different capability of
learning semantic features between 2D, 3D and P3D for the dense volumetric image
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Encoder\Decoder 3D 2D P3D
3D 84.09% 83.77% 84.20%
2D 83.66% 83.29% 84.08%
P3D 84.32% 84.69% 84.75%
Table 6.4. Performance (“Mean DSC”) of different encoder and decoder configurations
on NIH dataset evaluated by the same 4-fold cross validation. The architecture is manually
set with different choices from 2D, 3D and P3D. Ours obtains 85.15% in Table 6.1.
Method Mean DSC Max DSC Median
3D/3D 53.74± 30.66% 91.44% 60.55%
2D/2D 52.01 ± 31.50% 92.58% 63.27%
P3D/P3D 51.48 ± 32.46% 92.40% 63.89%
Table 6.5. Performance of different encoder and decoder configurations on MSD Lung
Tumors evaluated by the same 4-fold cross validation. The architecture is manually
configurated with different choices of 2D, 3D and P3D. Ours obtains 55.27% in Table 6.2.
segmentation problem drives us to naturally formulate it to be a neural architecture
search task. As it turns out, the automatic selection among the 2D, 3D and P3D
delivers the best performance with a mean DSC of 85.15% in Table 6.1.
6.4.5.2 Manual Setting on MSD Lung Tumors Dataset
On the MSD Lung Tumors dataset, we also report the manual architecture settings
of 3D/3D, 2D/2D and P3D/P3D, e.g., “3D/3D” stands for the configuration of only
choosing 3D in both Encoder and Decoder cells. As given in Table 6.5, the “3D/3D”
manual configuration achieves the best “Mean DSC” of 53.74 ± 30.66%. We suspect
that the lung cancers are located inside the lung organs, which needs the rich spatial
context to predict the abnormality. Consistent with what we observe in Sec. 6.4.5.1,
the neural architecture search idea outperforms all manual configurations to obtain a
best mean DSC of 55.27 ± 31.18% with an advantage of 1.53% over the “3D/3D” in
Table 6.2.
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6.5 Conclusion and Future Works
We propose to integrate neural architecture search into volumetric segmentation
networks to automatically find optimal network architectures between 2D, 3D, and
Pseudo-3D convolutions. The search process is computationally efficient and effective.
By searching in the relaxed continuous space, our method outperforms state-of-the-arts
on both normal and abnormal organ segmentation tasks. Moreover, the searched
architecture on one dataset can be well generalized to another one. In the future,
we would like to expand the search space to hopefully find even better segmentation
networks and reduce the computations.
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Chapter 7
Detecting Scatteredly-Distributed,
Small, and Critically Important
Objects in 3D Oncology Imaging
via Decision Stratification
Finding and identifying scatteredly-distributed, small, and critically important objects
in 3D oncology images is very challenging. We focus on the detection and segmentation
of oncology-significant (or suspicious cancer metastasized) lymph nodes (OSLNs),
which has not been studied before as a computational task. Determining and delineat-
ing the spread of OSLNs is essential in defining the corresponding resection/irradiating
regions for the downstream workflows of surgical resection and radiotherapy of various
cancers. For patients who are treated with radiotherapy, this task is performed by
experienced radiation oncologists that involves high-level reasoning on whether LNs
are metastasized, which is subject to high inter-observer variations. In this work, we
propose a divide-and-conquer decision stratification approach that divides OSLNs into
tumor-proximal and tumor-distal categories. This is motivated by the observation that
each category has its own different underlying distributions in appearance, size and
other characteristics. Two separate detection-by-segmentation networks are trained
per category and fused. To further reduce false positives (FP), we present a novel
global-local network (GLNet) that combines high-level lesion characteristics with
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features learned from localized 3D image patches. Our method is evaluated on a
dataset of 141 esophageal cancer patients with PET and CT modalities (the largest
to-date). Our results significantly improve the recall from 45% to 67% at 3 FPs per
patient as compared to previous state-of-the-art methods. The highest achieved OSLN
recall of 0.828 is clinically relevant and valuable.
7.1 Introduction
Measuring lymph node (LN) size and assessing its status are important clinical tasks,
usually used to monitor cancer diagnosis and treatment responses and to identify
treatment areas for radiotherapy. According to the Revised RECIST guideline [45],
[46], only enlarged LNs with a short axis more than 10-15 mm in computed tomography
(CT) images should be considered as abnormal. Such enlarged LNs have been the only
focus, so far, of LN segmentation and detection works [7], [47]–[53]. However, in cancer
treatment, besides the primary tumor, all metastasis-suspicious LNs are required to
be treated. This includes the enlarged LNs, as well as smaller ones that are associated
with a high positron emission tomography (PET) signal or any metastasis signs in
CT. This larger category is regarded as oncology significant lymph nodes (OSLNs).
Identifying the OSLNs and assessing their spatial relationship and causality with the
primary tumor is a key requirement for a desirable cancer treatment outcome [54].
Identifying OSLNs can be a daunting and time-consuming task, even for experienced
radiation oncologists. It requires using high-level sophisticated reasoning protocols
and faces strong uncertainty and subjectivity with high inter-observer variability [25].
To the best of our knowledge, this problem has not been previously tackled in a fully
automatized way. Our task on OSLNs detection is more challenging for the following
reasons: (1) Finding OSLNs is often performed using radiotherapy CT (RTCT), which,
unlike diagnostic CT, is not contrast-enhanced. (2) OSLNs exhibit low contrast with
surrounding tissues and can be easily confused with other anatomical structures, e.g.,
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(a) (b) (c)
(d) (e) (f)
(g)
Figure 7.1. (a,b,c) Three examples of enlarged LNs, which all prior work targets, in
contrast-enhanced CT. (d,e,f) Three instances of OSLNs, which our work focuses on, in
non-contrast RTCT. This category has not been studied before as a computational task.
(g) LN volume distributions for enlarged LNs from a public dataset [7], [53] and OSLNs in
our radiotherapy dataset.
vessels and muscles, due to shape and appearance ambiguity. (3) The size and shape
of OSLNs can vary considerably, and OSLNs are often scatteredly distributed at small
size in a large spatial range of anatomy locations. See Fig. 8.1 for an illustration of
the differences in appearance and size distribution between enlarged LNs the larger
category of OSLNs. We can observe that OSLNs have higher frequencies at smaller
sizes, challenging their detection. While, many previous works proposed automatic
detection systems for enlarged LNs in contrast-enhanced CT [2], [7], [47], [48], [51], [53],
[55], no work, as of yet, has focused on OSLN detection on non-contrast RTCT. Given
the considerable differences between enlarged LNs and OSLNs, further innovation is
required for robust and clinically useful OSLN detection.
Current clinical practices offer valuable insight in how to tackle this problem. For
instance, physicians condition their analysis of suspicious areas based on their distance
to the primary tumor. For LNs proximal to the tumor, physicians will more readily
identify them as OSLNs for the radiotherapy treatment. However, for LNs far away
from the tumor, physicians are more discriminating, only including them if there are
clear signs of metastasis, such as enlarged in size, increased PET signals, and/or other
CT-based evidence [107]. Hence, distance to the primary tumor plays a key role in
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Figure 7.2. (a) A coronal view of RTCT for an esophageal cancer patient. (b) The
manual annotated OSLN mask. (c) Tumor distance transform map overlaid on RTCT.
The primary tumor is indicated by red mask in the center and the white dash line shows
an example of the tumor proximal and distal region division. (d) PET imaging overlaid on
RTCT. The yellow arrows show several FP PET signals, and the green arrows indicate two
FN OSLNs where PET has weak or even no signals. A big central bright region in PET is
the primary tumor region.
physician’s decision making. Besides the distance, the PET modality is also highly
important, as it significantly increases sensitivity [25]. However, PET is noisy and
increased PET signals can often associate to normal physiological uptake. Moreover,
PET only highlights ∼ 33% of the OSLNs [108]. This is demonstrated in Fig. 7.2(d)’s
example, where PET provides key information in identifying OSLNs, which might be
too difficult to detect from RTCT only. Yet, the PET also exhibits false positives
(FPs) and false negatives (FNs). Based on this observation, an effective method to
leverage the complementary information in RTCT and PET is crucial, but this must
be done with care.
To solve this problem, we emulate and disentangle the above practices. First, we
propose and validate an intuitive and effective strategy that uses distance stratification
to decouple the underlying OSLN distributions into two “tumor-proximal” and “tumor-
distal” categories, followed by training separate networks to fit the class specific imaging
features to the task. LNs that are spatially close to the primary tumor site are more
suspicious (even if they are not enlarged); whereas spatially distal OSLNs may need
to be identified with both CT and PET imaging evidence. This type of decision
uncertainty stratification is evident in medical diagnosis and our work is one of the
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first computational realizations. Second, for each OSLN category, we implement a
3D detection-by-segmentation framework that fuses predictions from two independent
sub-networks, one trained on the RTCT imaging alone and the other learned via the
early fusion (EF) of three channels of RTCT, PET and the 3D tumor distance map
(Fig. 7.2(c)). RTCT depicts anatomical structures, which captures intensity appearance
and contextual information, serves as a good baseline diagnostic imaging modality. In
contrast, the EF stream takes into account PET’s metastasis functional sensitivities as
well as the tumor distance encoded in the distance transform map, which are both noisy
but informative. Along with the distance stratification, this produces four predictions,
which are all fused together as a late fusion (LF). This produces OSLN predictions
that achieve sufficiently high sensitivities in finding OSLNs, which complements the
high specificity but low sensitivity of human observers [25]. Missing true OSLNs can
cause oncologically critical areas to remain untreated. Third, we propose a global-local
network (GLNet) to further reduce the FP OSLN candidates obtained from above.
The GLNet has two modules, with each module corresponding to the global or local
spatial context. (1) For local context, we crop out any OSLN candidate region with
certain context margins and adopt 3D residual convolutions [61], [109] to extract
instance-wise localized deep feature maps. (2) For global context, we leverage the
ontology-based medical knowledge from the large-scale NIH DeepLesion [2] dataset via
a lesion tagging module [110], which provides high-level semantic information such as
body part and shape/texture/size attributes that cannot be easily captured from local
3D image patches. The strategy of looking at locally (i.e., the imaging space) and
globally (i.e., the semantic ontology space) is essential to mimic sophisticated clinical
reasoning protocols. Both the imaging texture and appearance and semantically
meaningful attributes are crucial to allow our workflow to filter out FPs while keeping
sensitivities high. Our contributions can be summarized as follows:
• To the best of our knowledge, we are the first to address the clinically critical
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task of detecting, identifying and characterizing OSLNs.
• We propose a novel 3D distance stratification strategy to divide and conquer the
complex distribution of OSLNs into tumor-proximal and tumor-distal classes, to
be solved separately, which emulates physician’s decision process.
• Besides RTCT, we incorporate the PET imaging modality and 3D tumor distance
maps into a two stream detection-by-segmentation network.
• We propose a novel GLNet to incorporate high-level ontology-derived semantic
attributes of OSLNs with localized features computed from RTCT/PET.
• We collect and evaluate on the largest dataset to date on chest and abdominal
radiotherapy. Our dataset comprises of 651 voxelwise-labeled OSLNs (by board-
certified radiation oncologists) of 141 esophageal cancer patients. Our system
significantly improves the detection recall from 45% to 67% at 3 FPs per scan,
compared against the previous state-of-the-art CT-based detection method [78].
The highest achieved recall of 0.828 for OSLNs detection is also clinically relevant
and valuable.
7.2 Related Work
Generic Lesion Detection: There are two popular approaches for generic lesion
detection: end-to-end [76]–[79] and two-stage methods [80]–[83]. End-to-end methods
have been extensively applied to the universal lesion detection task in the largest
general lesion dataset currently available, i.e., DeepLesion [2], and achieved encouraging
performance. Notably, a multi-task universal lesion analysis network (MULAN) [78]
so far achieves the best detection accuracy using a 3D feature fusion strategy and
Mask R-CNN [84] architecture.
In contrast, two-stage methods explicitly divide the detection task into candidate
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generation and FP reduction steps. The first step generates the initial candidates
at a high recall and FP rate and the second step focuses on reducing the FP rate
(especially the difficult ones) while maintaining a sufficient high recall. It decouples
the task into easier sub-tasks and allows for the optimal design of each sub-task,
which has shown to be more effective in problems like lung nodule [80], [83] and brain
lacune [81] detection as compared to the one-stage method. We adopt the two-stage
strategy for the OSLN detection to effectively incorporate different features, i.e., PET
imaging, tumor distance map and high-semantic lesion attributes, into each stage.
We demonstrate the necessity of our strategy by comparing with the state-of-the-art
(SOTA) universal lesion detector MULAN [78] in the experiment.
Lymph Node Detection and Segmentation: All previous works focus only
on enlarged LN detection and segmentation in contrast-enhanced CT. Conventional
statistical learning approaches [48]–[50], [55] employ hand-crafted image features, such
as shape, spatial priors, Haar filters, and volumetric directional difference filters, to
capture LN appearance and location. More recent deep learning methods achieve
better performance. [47], [51], [52] applies the FCN or Mask R-CNN to directly
segment LNs. In contrast, [7], [53] proposed a 2.5D patch-based convolutional neural
network (CNN) with random view aggregation to classify LNs given all LN candidates
already detected, and achieves SOTA classification accuracy for enlarged LNs. We
demonstrate the effectiveness of the local and global modules in our GLNet compared
with the 2.5D classification method [7].
Multi-Modal Image Analysis: The multi-modal imaging setup [111], [112]
is a common and effective representation for segmenting anatomical structures in
medical images. The pixel contrast and visual information in each modality is
different and complementary for many applications. In our work, RTCT and PET
have fundamentally different imaging physics, with RTCT corresponding to anatomy-
based structural imaging and PET to functional imaging. Recent deep learning
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Figure 7.3. The overall framework of our 2-stage OSLN detection method. The 1st-stage
adopts a divide-and-conquer distance stratification to divide OSLNs into tumor-proximal
(green) and tumor-distal (orange) categories. For each category, a two-stream network,
i.e., CT stream (no fill) and CT, PET and tumor-distance early fusion stream (solid fill), is
designed to learn the specific features for this category. After that, the predictions of the
two streams are fused together via the “max” operation to achieve high recall. The GLNet
of the 2nd-stage takes the OSLN candidates from the 1st-stage, and passes it through
the local and global modules to reject FPs, leading to a final set of OSLNs with clinically
relevant recall and low FPs.
approaches [83], [113]–[115] have exploited different fusion strategies for PET/CT, e.g.,
early, late or chained fusion. In our 1st-stage, we propose a 2-stream deep network
segmentation workflow (encoding RTCT alone or combined RTCT/PET and tumor
distance map, respectively) and implement a concise late probability fusion scheme.
This simple two-stream fusion strategy effectively generates the OSLN candidates with
a high recall at a reasonable FP rate, which is desirable for the downstream 2nd-stage
FP reduction.
7.3 Method
Fig. 8.2 illustrates our two-stage framework, which combines OSLN candidate genera-
tion with FP rejection. In the 1st-stage, we group OSLNs into two categories based
on their distances to the primary tumor via distance stratification. For each category,
a two-stream detection-by-segmentation network is designed to effectively incorporate
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and fuse the RTCT and PET images, along with a tumor distance transform map.
Results from two categories are merged together to produce the OSLN candidates.
The goal of the 1st-stage is to have a set of OSLN candidates with high recall while
keeping FPs to a reasonable number. In the 2nd-stage, the GLNet, composed of local
and global modules, is proposed to serve as a selective classifier to reject OSLN FP
candidates (especially the difficult ones) while preserving sufficient recall.
7.3.1 1st-Stage: Candidate Generation
Assuming N data samples, we denote a dataset as S =
{︂(︂
XCTn , XPETn , YTn , YLNn
)︂}︂N
n=1
,
where XCTn , XPETn , YTn and YLNn represent the non-contrast RTCT, registered PET,
the tumor mask and the ground truth LN segmentation mask, respectively. Without
loss of generality we drop n for conciseness for the rest of the paper. The mask YT is
a 3D volume with a binary value yi at each spatial location i to indicate whether the
voxel xi is the OSLN target. To encode the tumor distance information, we compute
the 3D signed distance transform map from the primary tumor YT, denoted as XD,
where each voxel xDi ∈ XD represents the distance between this voxel to the nearest
boundary of the primary tumor. Let Γ(YT) be a function that computes boundary
voxels of the tumor. The distance transform value at a voxel xDi is computed as
XD(xDi ) =
⎧⎪⎨⎪⎩
min
q∈Γ(YT)
d(xDi , q) if xDi /∈ YT
− min
q∈Γ(YT)
d(xDi , q) if xDi ∈ YT
, (7.1)
where d(xDi , q) is a distance measure from xDi to q. We choose to use Euclidean distance
in our work and use Maurer’s efficient algorithm [116] to compute the XD. Note that
XCT and XPET and YT are already given and XD is pre-computed at the inference
time.
We denote segmentation models as a mapping: P = f(X ; Θ), where X is a set of
inputs, which may consist of a single modality or a concatenation of multiple modalities.
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Θ indicates model parameters, and P denotes the predicted probability volume.
Specifically in a neural network, Θ is parameterized by the network parameters.
7.3.1.1 Distance-Based Stratification
Based on XD, we divide image voxels into two groups, xprox and xdis, to be tumor-
proximal and tumor-distal, respectively, where prox = {i|xDi ≤ d} and dis = {i|xDi >
d}. In this way, we divide all OSLNs into two categories, and train separate segmenta-
tion models for each. By doing this, we break down the challenging OSLN segmentation
problem into two simpler sub-problems, each of which can be more easily conquered.
This allows the OSLN segmentation method to emulate the clinician decision process,
where tumor-proximal LNs are more readily considered oncology-significant, whereas
a more conservative process, with differing criteria, is used for tumor-distal LNs. See
Fig. 8.2 for the distance stratification demonstration. Prediction volumes generated by
the tumor-proximal or tumor-distal models are denoted as Pprox and Pdis, respectively.
7.3.1.2 Two-Stream Detection-by-Segmentation Fusion
For each OSLN category, we again emulate the physician’s diagnostic process by fully
exploiting the complementary information within the RTCT, PET and tumor distance
map. Specifically, for each OSLN category, we design a two-stream 3D segmentation
workflow that fuses predictions from two independent sub-networks, one trained using
the RTCT alone (CT stream), and the other trained using the three channels of
RTCT, PET and the tumor distance map jointly (early fusion stream). In this way we
generate predictions based on only structural appearance, complementing them with
additional predictions incorporating PET’s auxiliary functional sensitivity and the
tumor distance-map’s location context. We denote prediction volumes from the RTCT
and early fusion stream models as PCT(.) and PEF(.) , respectively, where the subscript
may be either “prox” or “dis” for the tumor-proximal or tumor-distal categories,
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respectively. The result is four separate predictions. To ensure a high recall of OSLN
detection in this stage, we apply a straightforward yet effective late fusion by taking
the element-wise max and union operations of the four predictions:
PLF = {pi|pi = union{max{pCTprox,i, pEFprox,i}, max{pCTdis,i, pEFdis,i}}}, (7.2)
where p(.)(.),i ∈ P
(.)
(.) and i indexes individual voxel locations. Stratifying OSLNs by
tumor distance and performing two stream fusion are both crucial for a high recall.
From the final segmentation probability PLF, we derive the binary segmentation
mask B by thresholding, and then calculate the OSLN instance candidates as the
input to the 2nd-stage.
7.3.2 2nd-Stage: False Positive Reduction
The goal of the 2nd-stage is to reject as many FPs as possible while maintaining a
sufficiently high recall. We first aggregate all predicted OSLN instances from the
1st-stage to be R =
{︂(︂
CCTm , CPETm , lm
)︂}︂M
m=1
as the OSLN candidates set, where CCTm
and CPETm denote the local RTCT and PET image patches cropped at the mth OSLN
candidate, respectively, and the binary scalar lm is the label indicating if this instance
is a true OSLN. We formulate a classification model: q = g(C; Φ), where C represents
the input image patches, Φ stands for model parameters, and q denotes the predicted
probability. Here, when appropriate, we drop the m for simplicity.
To design a highly effective OSLN classifier, especially for the hard FPs, we propose
a global and local network (GLNet) to leverage both local (CT appearance and PET
signals) and global (spatial prior and other attributes) features. We describe their
details in the following subsections.
7.3.2.1 Local Module in Global-Local Network
For the local module, we adopt a multi-scale 3D CNN model with a 3D ROI-GAP
pooling layer [109] to extract OSLN local features from the image patch C. Unlike
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the 2.5D input patch used in [7], the 3D CNN explicitly uses 3D spatial information,
improving classification performance. Either CT or CT+PET patches can be fed
into the local model, and we evaluate both options. The features generated by each
convolutional block separately pass through a 3D ROI-GAP pooling layer and a fully
connected layer to form a 256D vector, which are then concatenated together to a
multi-scale local representation for the OSLN instance. Since we use four CNN blocks,
this leads to a total of 4 × 256 = 1024-dimensional feature vector, which is denoted as
v. See the 2nd-stage illustration in Fig. 8.2.
7.3.2.2 Global Module in Global-Local Network
For the global module, we migrate the ontology-based medical knowledge from the large-
scale DeepLesion [2] dataset, via a pretrained lesion tagging module, i.e., LesaNet [110].
Trained from radiology reports, LesaNet predicts high-level semantic lesion properties
in the form of a 171-dimensional vector describing the lesion’s body part, type
and attributes. These information may not be easily captured from local image
patches. We use the prediction of LesaNet on the mth OSLN candidates to generate
a 171-dimensional feature vector tm, which provides complementary information to
distinguish a true OSLN from false ones. For example, one body-part attribute from
the feature vector indicates whether the lesion is in the “muscle”, which may be
confused with OSLNs when only analyzing the small local image patch, but are easier
to identify under a global context. These kinds of FP candidates can be safely rejected
using the global properties. LesaNet also predicts body parts like hilum LN, subcarinal
LN, pretracheal LN and attributes like hypo-attenuation, tiny, oval, which are all
relevant properties to distinguish true OSLNs from false ones.
To combine the strength of local image-based features and global OSLN properties,
the GLNet concatenates vm and tm and passes through a fully connected layer to
generate the final OSLN classification score, as illustrated in Fig. 8.2.
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Figure 7.4. Visualization of segmentation contours in axial view or coronal views, and
3D mask volume rendering of two cases (left, and right). All masks/contours are LNs
candidates from the first stage, where red ones are rejected in the 2nd-stage. Compared
with ground truth LNs, TP and FP are colored in green and blue, respectively. Best viewed
in color.
7.4 Experiments
In Fig. 7.4, we provide visual examples of our OSLN detection results. First, we can
find that a large number of OSLN candidates are generated after the 1st-stage, to
warrant a high recall. Second, the majority of OSLN candidates are effectively reduced
by our proposed GLNet classifier, while the true positives in the 1st-stage are kept
after the false positive reduction, which is desirable. Below we elaborate further on
our experiments, providing dataset and implementation details along with extensive
quantitative analyses.
7.4.1 Datasets
We collected an in-house dataset to evaluate our 1st-stage performance as well as the
overall two-stage performance. We collected 141 non-contrast RTCTs of anonymized
esophageal cancer patients, all undergoing radiotherapy treatments. Radiation oncolo-
gists labeled the 3D segmentation masks of the primary tumor and all OSLNs treated
by radiotherapy. In total, there is a non-contrast RTCT scan and a PET/CT for
each of the 141 patients and 651 OSLNs with voxel-wise labels in the mediastinum or
upper abdomen regions. This is the largest annotated OSLN dataset in the chest and
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abdominal region to-date. We register the PET images to RTCT using the registration
method in [113]. For evaluation, we randomly split the annotated 141 patients into 84
for training, 23 for validation, and 34 for testing. In our experiments, we resample
RTCT and PET images to have a consistent spatial resolution of 1 × 1 × 2.5 mm.
For data preprocessing, we truncate Hounsfield unit values of the RTCT to be within
[−200, 300]. We also calculate the mean and standard deviation values of PET images
across the entire training set and then normalize all PET images with these values.
7.4.2 Implementation Details
In the first stage, for training the OSLN detection-by-segmentation network, we crop
sub-volumes of 96 × 96 × 64 from the 3D images of RTCT, registered PET and the
tumor-LN distance map. For the distance stratification, we set d = 70 mm to divide
OSLN instances to tumor-proximal and tumor-distal sub-groups as suggested by our
physician, and train the tumor-proximal and tumor-distal models separately. For data
augmentation, we use straightforward and effective augmentations on training patches,
i.e., rotation (90°, 180°, and 270°) with a probability of 0.5 and flips in the axial view
with a probability of 0.25. We can choose any popular segmentation network as our
1st-stage backbone, and we opt for the standard 3D UNet [10] as it gives the best
performance in our network backbone ablation study in Sec. 7.4.4. Models are trained
on two NVIDIA Quadro RTX 6000 GPUs with a batch size of 8 for 50 epochs. The
RAdam [117] optimizer with a learning rate of 0.0001 is used with a momentum of 0.9
and a weight decay of 0.0005. For testing, we use a computationally efficient way to
inference, i.e., sub-volumes of 224 × 224 × 64 are cropped along the vertical axis with
the horizontal center the same as the center of lung masks [118]. These sub-volume
predictions are aggregated to obtain the final OSLN segmentation results.
In the 2nd-stage, to train the local module of GLNet, the input images are generated
by cropping a 48×48×32 sub-volume centered around each predicted OSLN candidate
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from the 1st-stage. If the size of the predicted OSLN is larger than 48 × 48 × 32, we
resize the sub-volume so that it contains at least an 8-voxel margin of the background
along each dimension to ensure sufficient background context. The bounding boxes
(bbox) for the 3D ROI-GAP pooling layer in Sec. 7.3.2 are generated by randomly
jittering the bbox around the predicted OSLN with a 3-voxel range in each dimension.
For the global module of GLNet, we use the publicly available LesaNet [110] pre-
trained on the DeepLesion dataset. The input of LesaNet is a 120×120 2D CT image
patch around the OSLN candidate. The overall GLNet is trained using Adam [119]
optimizer with a learning rate of 0.0001 and batch size of 32 for 10 epochs.
7.4.3 Evaluation Metrics
We first describe the hit, i.e., the correct detection, criteria for OSLN detection when
using the segmentation results. For an OSLN prediction from the 1st-stage, if it
overlaps with any ground-truth OSLN, we treat it as a hit provided that its estimated
radius is similar to the radius of the ground-truth OSLN. After confirming with our
physician, a predicted radius must be within a factor of [0.5, 1.5] to the ground-truth
radius.
7.4.3.1 Recall and Precision
We assess the performance of the 1st-stage by reporting the recall at a range of desired
precision points. Note that the goal of the 1st-stage is to achieve a high recall (even
with quite a few FPs) so that the 2nd-stage has a high upper-bound recall to work
with while it filters out FPs. We report the mean recall (mRecall) at a precision range
of [0.10, 0.20] to reflect the model performance. We also report the recall at a precision
of 0.15, which is the operating point we choose to generate inputs for the 2nd-stage.
This operating point was chosen after confirming with our radiation oncologist. Both
the recall and precision are macro-averaged across patients.
98
Backbone Recall@0.15 mRecall@0.10-0.20
CT EF CT EF
3D-UNet 0.736 0.732 0.762 0.722
SE-UNet 0.686 0.705 0.693 0.705
HRNet 0.524 0.656 0.538 0.638
PSNN 0.709 0.574 0.714 0.592
Table 7.1. Ablation study of different backbones for the CT and early fusion streams.
Input Recall@0.15 mRecall@0.10-0.20
w/ w/o w/ w/o
LF 0.828 0.786 0.817 0.732
EF 0.788 0.732 0.760 0.722
CT 0.772 0.736 0.772 0.762
Table 7.2. 3D UNet performance with (“w/”) and without(“w/o”) distance stratfication.
All three settings, CT, EF, and LF, are tested.
7.4.3.2 FROC
To evaluate both the complete workflow (1st+2nd-stage), we compute the free response
operating characteristic (FROC), which measures the recall against different numbers
of FPs allowed per patient. We report the average recall (mFROC) at 2, 3, 4, 6 FPs
per patient study. Besides the mFROC, we also report the best F1 score a model can
achieve.
7.4.4 1st-Stage Ablation Study
7.4.4.1 Segmentation Network Backbone
We evaluated different segmentation backbones for the OSLN candidate generation, i.e.,
standard UNet [10], UNet with squeeze-and-excitation (SE) block [120], HRNet [121],
and PSNN [113]. As shown in Table 7.1, the standard 3D UNet [10] consistently
outperforms other backbones. For PSNN [113], it probably has difficulty handling
this challenging task (dealing with small objects) due to its simplistic “upsampling”
decoders. For the HRNet [121], due to its memory-hungry computations, we can
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only add the high resolution features after two pooling layers, which is undesired for
segmenting OSLNs. The attention module from the SE block [120] does not help with
this segmentation task either.
7.4.4.2 Distance Stratification and Two-Stream Network Fusion
We verify the effectiveness of the proposed distance stratification method under
different settings. As shown in Table. 7.2, among all settings, i.e., CT, early fusion
(EF), and late fusion (LF), the distance stratification consistently improves recall@0.15
by 4% − 5%. Similar improvements are seen for mRecall@0.1-0.2. These results
strongly support our use of distance stratification, which is shown to be effective under
different input settings.
Table 7.2 also reveals the importance of using and fusing different streams. As
we can see, the CT stream and the EF stream achieve similar performance to each
other, regardless of whether distance stratification is used or not. However, when
the two streams are combined together using LF, marked improvements are observed.
For example, the recall@0.15 gains 4%-5%, and the mRecall@0.1-0.2 shows similar
improvements. These quantitative results validate the effectiveness of the proposed
distance stratification and the two-stream network fusion.
7.4.5 2nd-stage Ablation Study
7.4.5.1 Necessity of the 2nd-stage
To gauge the impact of the 2nd-stage, we first directly evaluate the OSLN detection
accuracy using the 1st-stage alone. Specifically, the detection score of each OSLN
instance is determined by averaging the segmentation probability for every voxel
within the segmentation mask. All “1st-stage only” results in Tab. 8.1 are marked
by “#”. Focusing first on the LF setting, when using the 1st-stage alone it provides
0.441 F1 and 0.478 mFROC. When adding a second-stage classifier only accepting CT
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as input, the F1 scores and mFROC are improved to 0.513 and 0.576, respectively.
Providing the PET image and global tags to the 2nd-stage classifier boosts performance
even further to 0.552 and 0.645 for F1 scores and mFROC, respectively. These are
clinically impactful gains. Finally, regardless of the 1st-stage setting (LF, EF, or CT),
the 2nd-stage classifier provides clear improvement. This proves the versatility and
strength of our workflow.
7.4.5.2 Role of Local and Global Modules in GLNet
To show the necessity of both the local and global GLNet modules, we also evaluated
purely local and purely global 2nd-stage classification performance. As can be seen
in Table 8.1, regardless of which 1st-stage setting is used, a purely local 2nd-stage
(e.g. last 2nd and 3rd rows) outperforms a purely global 2nd-stage (e.g. last 4th row).
This indicates that the high-level semantic features migrated from the general lesion
tagging model, i.e., LesaNet [110], are less effective than the local OSLN features
extracted from CT or CT+PET. However, when combining the global tags with the
local patches using the proposed GLNet, mFROC performance is increased from 0.594
to 0.645 (when using the LF 1st-stage setting). This demonstrates that both local
and global features contribute to our ultimate performance. These observations are
also valid when using the CT or EF settings for the 1st-stage.
7.4.6 Comparison to the State-of-the-Art
Table. 8.1 also compares the proposed two-stage OSLN detection method with 2 state-
of-the-art methods, i.e., the multi-task universal lesion analysis network (MULAN) [78]
(achieves the best general lesion detection results in the DeepLesion dataset) and a
2.5D CNN method for classifying enlarged LNs [7] (achieves the best 2nd-stage LN
classification results in the enlarged LN dataset). We retrain the MULAN using both
CT and CT+PET as inputs on our radiotherapy dataset. The tagging information is
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1st-Stage Setting 2nd-Stage Inputs Evaluation Metrics
CT PET Tag F1 mFROC
CT# 0.407 0.431
EF# Not Applied 0.370 0.395
LF# 0.441 0.478
CT [7] ✓ 0.220 0.067
CT ✓ 0.380 0.408
CT ✓ 0.421 0.449
CT ✓ ✓ 0.450 0.491
CT (GLNet) ✓ ✓ ✓ 0.513 0.563
EF [7] ✓ 0.225 0.092
EF ✓ 0.397 0.444
EF ✓ 0.423 0.473
EF ✓ ✓ 0.469 0.518
EF (GLNet) ✓ ✓ ✓ 0.507 0.572
LF [7] ✓ 0.257 0.143
LF ✓ 0.471 0.531
LF ✓ 0.513 0.576
LF ✓ ✓ 0.526 0.594
LF (GLNet) ✓ ✓ ✓ 0.552 0.645
End-to-End Method Inputs Evaluation Metrics
CT PET Tag F1 mFROC
MULAN [78] ✓ ✓ ✓ 0.436 0.475
MULAN [78] ✓ ✓ 0.335 0.348
Table 7.3. Performance comparison of different methods on the testing set. The “1st-
Stage Setting” column denotes which setting is used to generate OSLN candidates. “#”
means we directly evaluate based on 1st-stage instance-wise segmentation scores. The
“2nd-Stage Inputs” column indicates which inputs are provided to the 2nd-stage classifier.
Boldface denotes our chosen 2nd-stage classifier, evaluated across different 1st-stage
settings. We also compare against previous state-of-the-arts, the [7] and the end-to-end
MULAN system [78].
naturally incorporated in MULAN regardless of input channels. Several conclusions can
be drawn. First, MULAN’s results, based on the CT+PET input (0.475 mFROC), are
better than those based on the CT alone (0.348 mFROC), which again demonstrates
the importance of PET imaging in the OSLN detecting task, even when using a single
end-to-end trained model. Second, MULAN’s best performance is just comparable
with our best 1st-stage-only results, i.e., (LF#). This demonstrates the effectiveness
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of our 1st-stage with distance stratification and the two-stream network fusion. Third,
our complete pipeline, regardless of the 1st-stage settings, significantly outperforms
the best MULAN results, e.g., CT (GLNet) achieves an mFROC score of 0.563 as
compared to 0.475 from MULAN, whereas LF (GLNet) further boosts the mFROC
to 0.645. This is a 22% improvement and highlights the advantages of our two-stage
method, which is tailored to achieve maximum performance gain on the challenging
and unique OSLN problem.
Similar to our 2nd-stage, the 2.5D CNN method of [7] is designed to classify LN
candidates, but it was characterized only on enlarged LN candidates using contrast-
enhanced CT. We trained it using our non-contrast CT local patches under different
1st-stage settings, i.e., CT, EF and LF. Note that it has the worst performance among
all 2nd-stage classifiers, with a best mFROC of only 0.143. This large performance
degradation, particularly compared to our CT-only 2nd-stage classifier, is probably due
to its 2.5D input setup and the missing of PET information. Although the 2.5D inputs
and 3 orthogonal views is efficient for enlarged LN classification [7], this pseudo 3D
analysis cannot fully leverage the 3D information that seems important to differentiate
OSLNs from background.
7.5 Conclusion and Future Works
We proposed a new two-stage approach to automatically detect and segment oncology
significant lymph nodes (OSLNs) from non-contrast CT and PET, which has not been
previously studied as a computational task. In the 1st-stage, we introduce a divide-
and-conquer distance stratification method by dividing OSLNs into tumor-proximal
and tumor-distal categories; followed by training separate detection-by-segmentation
networks to learn the category specific features aimed to decouple this challenging
task into two easier ones. In the 2nd-stage, we propose the GLNet to further reduce
the false positives from the 1st-stage, by combining local appearance features from
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CT/PET patches and global semantic information migrated from a general lesion-
characteristics-tagging model. Our method is evaluated on the largest OSLN dataset
of 141 esophageal cancer patients. Our proposed framework significantly improves
the recall from 45% to 67% at the 3 false-positive rates per patient as compared
to previous state-of-the-art methods. Thus, our work represents an important step
forward toward OSLNs detection and segmentation. In the future, we would like to
consider the relationship among OSLNs and the primary tumors in the false positive
reduction stage.
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Chapter 8
Lymph Node Gross Tumor Volume
Detection and Segmentation via
Distance-based Gating using 3D
CT/PET Imaging in Radiotherapy
Finding, identifying and segmenting suspicious cancer metastasized lymph nodes from
3D multi-modality imaging is a clinical task of paramount importance. In radiotherapy,
they are referred to as Lymph Node Gross Tumor Volume (GTVLN 1). Determining and
delineating the spread of GTVLN is essential in defining the corresponding resection and
irradiating regions for the downstream workflows of surgical resection and radiotherapy
of various cancers. In this work, we propose an effective distance-based gating approach
to simulate and simplify the high-level reasoning protocols conducted by radiation
oncologists, in a divide-and-conquer manner. GTVLN is divided into two subgroups of
“tumor-proximal” and “tumor-distal”, respectively, by means of binary or soft distance
gating. This is motivated by the observation that each category can have distinct
though overlapping distributions of appearance, size and other LN characteristics. A
novel multi-branch detection-by-segmentation network is trained with each branch
specializing on learning one GTVLN category features, and outputs from multi-branch
are fused in inference. The proposed method is evaluated on an in-house dataset
of 141 esophageal cancer patients with both PET and CT imaging modalities. Our
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results validate significant improvements on the mean recall from 72.5% to 78.2%,
as compared to previous state-of-the-art work. The highest achieved GTVLN recall
of 82.5% at 20% precision is clinically relevant and valuable since human observers
tend to have low sensitivity (∼ 80% for the most experienced radiation oncologists, as
reported by literature [25]).
8.1 Introduction
Assessing the lymph node (LN) status in oncology clinical workflows is an indispensable
step for the precision cancer diagnosis and treatment planning, e.g., radiation therapy
or surgical resection. The class of enlarged LN is defined by the revised RECIST
guideline [46] if its short axial axis is more than 10-15 mm in computed tomography
(CT). In radiotherapy treatment, both the primary tumor and all metastasis suspicious
LNs must be sufficiently treated within the clinical target volume with the proper
doses [17]. We refer to these LNs as lymph node gross tumor volume or GTVLN , which
includes enlarged LNs, as well as smaller ones that are associated with a high positron
emission tomography (PET) signal or any metastasis signs in CT [107]. Accurately
identifying and delineating GTVLN , to be spatially included in the treatment area, is
essential for a desirable cancer treatment outcome [54].
It is an extremely challenging and time-consuming task to identify GTVLN , even for
experienced radiation oncologists. High-level sophisticated clinical reasoning guidelines
are needed, leading to the risk of uncertainty and subjectivity with high inter-observer
variabilities [25]. It is arguably more difficult than detecting the more general enlarged
LNs. (1) Finding GTVLN is often performed using radiotherapy CT (RTCT) that
(unlike diagnostic CT) is not contrast-enhanced. Hence the metastasis signs for
identifying GTVLN are subtler. (2) GTVLN itself has poor contrast. Because of the
1Both the GTVLN and the OSLNs in Chapter 7 have the same definition and refer to the same
thing.
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shape and appearance ambiguity, it can be easily confused with vessels or muscles. (3)
The size and shape of GTVLN vary considerably with large amounts of smaller ones
that are harder to detect. Refer to Fig. 8.1 (top row) for an illustration of GTVLN .
While many previous works attempt to detect enlarged LNs using contrast-enhanced
CT [2], [7], [47], [48], [51], [53], [55], no work, as of yet, has studied the GTVLN
detection in non-contrast RTCT scans. Given the evident differences between the
enlarged LNs and GTVLN , further innovations are required for the robust GTVLN
detection and segmentation.
Valuable insights from physicians’ clinical diagnosis and analysis process can be
leveraged to tackle this problem. As one of the primary cues, human observers
condition the analysis of GTVLN based on the LNs’ distance with respect to the
corresponding primary tumor location. For LNs proximal to the tumor, physicians
more readily identify them as GTVLN in radiotherapy treatment. However, for LNs
distal to the tumor, they use more strict criteria to include if there are clear signs
of metastasis, e.g., enlarged size, increased PET signals, and/or other CT based
evidence [107]. Hence, the distance measure relative to the primary tumor plays a key
role during physician’s decision making. Besides the distance, the PET modality is
also of high importance. Although as a noisy imaging channel, it has shown to be
helpful in increasing the GTVLN detection sensitivity [25]. As demonstrated in Fig. 8.1
(bottom row), PET provides critically distinct information, yet, it also exhibits false
positives (FPs) and false negatives (FNs).
In this paper, we imitate the physician’s diagnosis process to tackle the problem of
GTVLN detection and segmentation. (1) We introduce a distance-based gating strategy
in a multi-task framework to divide the underlying GTVLN distributions into “tumor-
proximal” and “tumor-distal” categories and solve them accordingly. Specifically, a
multi-branch network is proposed to adopt a shared encoder and two separate decoders
to detect and segment the “tumor-proximal” and “tumor-distal” GTVLN , respectively.
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Figure 8.1. Top row (a-d): examples of the GTVLN (red arrow) with varying size and
appearance at scatteredly distributed locations. Bottom row (e-h): (e) A coronal view of
RTCT for an esophageal cancer patient. (f) The manual annotated GTVLN mask. (g)
The tumor distance transformation map overlaid on RTCT, where the primary tumor is
indicated by red in the center and the white dash line shows an example of the binary
tumor proximal and distal region division. (h) PET imaging shows several FPs with high
signals (yellow arrows). Two FN GTVLN are indicated by green arrow where PET has
even no signals on a GTVLN .
A distance-based gating function is designed to generate the corresponding GTVLN
sample weights for each branch. By applying the gating function at the outputs of
decoders, each branch is specialized to learn the “tumor-proximal” or “tumor-distal”
GTVLN features that emulates physician’s diagnosis process. (2) We leverage the
early fusion (EF) of three modalities as input to our model, i.e., RTCT, PET and
3D tumor distance map (Fig. 8.1(bottom row)). RTCT depicts anatomical structures
capturing the intensity, appearance and contextual information, while PET provides
metastasis functional activities. Meanwhile, the tumor distance map further encodes
the critical distance information in the network. Fusion of these three modalities
together can effectively boost the GTVLN identification performance. (3) We evaluate
on a dataset comprising 651 voxel-wise labeled GTVLN instances in 141 esophageal
cancer patients, as the largest GTVLN dataset to date for chest and abdominal
radiotherapy. Our method significantly improves the detection mean recall from
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72.5% to 78.2%, compared with the previous state-of-the-art lesion detection method
[78]. The highest achieved recall of 82.5% is also clinically relevant and valuable. As
reported in [25], human observers tend to have relatively low GTVLN sensitivities,
e.g., ∼ 80% by even very experienced radiation oncologists. This demonstrates our
work’s clinical values.
8.2 Method
Fig. 8.2 shows the framework of our proposed multi-branch GTVLN detection-by-
segmentation method. Similar to [20], [122] which are designed for the pancreatic
tumors, we detect GTVLN by segmenting them. We first compute the 3D tumor
distance transformation map (Sec. 8.2.1), based on which any GTVLN is divided into
the tumor-proximal or tumor-adjacent subcategory. Next, a multi-branch detection-
by-segmentation network is designed where each branch focuses on one subgroup of
GTVLN segmentation (Sec. 8.2.2). This is achieved by applying a binary or soft
distance-gating function imposed on the penalty function at the output of the two
branches (Sec. 8.2.3). Hence, each branch can learn specific parameters to special-
ize on segmenting and detecting the tumor-proximal and tumor-adjacent GTVLN ,
respectively.
8.2.1 3D Tumor Distance Transformation
To stratify GTVLN into tumor-proximal and tumor-distal subgroups, we first compute
the 3D tumor distance transformation map, denoted as XD, from the primary tumor
O. The value at each voxel xi represents the shortest distance between this voxel and
the mask of the primary tumor. Let B(O) be a set that includes the boundary voxels
of the tumor. The distance transformation value at a voxel xi is computed as
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Figure 8.2. The overall framework of our proposed multi-branch GTVLN detection and
segmentation method. The light green part shows the encoder path, while the light yellow
and light blue parts show the two decoders, respectively. The number of channels is
denoted either on the top or the bottom of the box.
XD(xi) =
⎧⎨⎩ minq∈B(O)d(xi, q) if xi /∈ O0 if xi ∈ O , (8.1)
where d(xi, q) is the Euclidean distance from xi to q. XD can be efficiently computed
using algorithms such as the one proposed in [116]. Based on XD, GTVLN can be
divided into tumor-proximal and tumor-distal subgroups using either binary or soft
distance-gating function as explained in detail in Sec. 8.2.3.
8.2.2 Multi-branch Detection-by-Segmentation via Distance
Gating
GTVLN identification is implicitly associated with their distance distributions to the
primary tumor in the diagnosis process of physicians. Hence, we divide GTVLN into
tumor-proximal and tumor-distal subgroups and conduct detection accordingly. To do
this, we design a multi-branch detection-by-segmentation network with each branch
focusing on segmenting one GTVLN subgroup. Each branch is implemented by an
independent decoder to learn and extract the subgroup specific information, while
they share a single encoder to extract the common GTVLN image features. Assuming
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there are N data samples, we denote a dataset as S =
{︂(︂
XCTn , XPETn , XDn , Yn
)︂}︂N
n=1
,
where XCTn , XPETn , XDn and Yn represent the non-contrast RTCT, registered PET,
tumor distance transformation map, and ground truth GTVLN segmentation mask,
respectively. Without the loss of generality, we drop n for conciseness in the rest of
this paper. The total number of branches is denoted as M , where M = 2 in our case.
A CNN segmentation model is denoted as a mapping function E : P = f (X ; Θ), where
X is a set of inputs, which consists of a single modality or a concatenation of multiple
modalities. Θ indicates model parameters, and P means the predicted probability
volume. Given that p(yi|xi; Θm) represents the predicted probability of a voxel xi ∈ X
being the labeled class from the mth branch, the overall negative log-likelihood loss
aggregated across M branches can be formulated as:
L =
∑︂
m
Lm(X ; Θm, Gm) = −
∑︂
i
∑︂
m
gm,i log(p(yi|xi; Θm)), (8.2)
where G = {Gm}Mm=1 is introduced as a set of volumes containing the transformed
gating weights at each voxel based on its distance to the primary tumor. At every
voxel xi ∈ G, the gating weights satisfies
∑︁
m gm,i = 1.
8.2.3 Distance-based Gating Module
Based on the tumor distance map XD, our gating functions can be designed to
generate appropriate GTVLN sample weights for different branches so that each
branch specializes on learning the subgroup specific features. In our case, we explore
two options: (1) binary distance gating and (2) soft distance gating.
Binary Distance Gating (BG). Based on the tumor distance map XD, we divide
image voxels into two groups, xprox and xdis, to be tumor-proximal and tumor-distal,
respectively, where prox = {i|xDi ≤ d0, xDi ∈ XD} and dis = {i|xDi > d0, xDi ∈ XD}.
Therefore the gating transformations for two decoders are defined as Gprox = 1[xDi ≤
d0] and Gdist = 1 − Gprox, where 1[·] is an indicator function which equals one if its
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argument is true and zero otherwise. In this way, we divide the GTVLN strictly into
two disjoint categories, and each branch focuses on decoding and learning from one
category.
Soft Distance Gating (SG). We further explore a soft gating method that
linearly changes the penalty weights of GTVLN samples as they are closer or further
to the tumor. This can avoid a sudden change of weight values when samples are near
the proximal and distal category boundaries. Recommended by our physician, we
formulate a soft gating module based on XD as following:
Gprox(xi) =
⎧⎪⎪⎨⎪⎪⎩
1 − x
D
i −dprox
ddist−dprox
if dprox < xDi ≤ ddist
1 if xDi ≤ dprox
0 if xDi > ddist
, (8.3)
and Gdist(xi) = 1 − Gprox(xi) accordingly.
8.3 Experiments
8.3.1 Dataset and Preprocessing
Dataset. We collected 141 non-contrast RTCTs of esophageal cancer patients, with all
undergoing radiotherapy treatments. Radiation oncologists labeled 3D segmentation
masks of the primary tumor and all GTVLN . For each patient, we have a non-contrast
RTCT and a pair of PET/CT scans. There is a total of 651 GTVLN with voxel-wise
annotations in the mediastinum or upper abdomen regions, as the largest annotated
GTVLN dataset to-date. We randomly split patients into 60%, 10%, 30% for training,
validation and testing, respectively.
Implementation Details. In our experiments, PET scan is registered to RTCT
using the similar method described in [113]. Then all coupling pairs of RTCT and
registered PET images are resampled to have a consistent spatial resolution of 1×1×2.5
mm. To generate the 3D training samples, we crop sub-volumes of 96 × 96 × 64 from
the RTCT, registered PET and the tumor distance map around each GTVLN as well
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as randomly from the background. For the distance-gating related parameters, we
set d0 = 7 cm as the binary gating threshold, and dprox = 5 cm and ddist = 9 cm as
the soft gating thresholds, respectively, as suggested by our clinical collaborator. We
further apply random rotations in the x-y plane within 10 degrees to augment the
training data.
Detection-by-segmentation models are trained on two NVIDIA Quadra RTX 6000
GPUs with a batch size of 8 for 50 epochs. The RAdam [117] optimizer with a learning
rate of 0.0001 is used with a momentum of 0.9 and a weight decay of 0.0005. For
inference, 3D sliding windows with a sub-volume of 96 × 96 × 64 and a stride of
64 × 64 × 32 voxels are processed. For each sub-volume, predictions from two decoders
are weighted and aggregated according to the gating transformation Gm to obtain
the final GTVLN segmentation results.
Evaluation Metrics. We first describe the hit criteria, i.e., the correct detection,
for our detection-by-segmentation method. For an GTVLN prediction, if it overlaps
with any ground-truth GTVLN , we treat it as a hit provided that its estimated radius
is similar to the radius of the ground-truth GTVLN within the range of [0.5, 1.5]. The
performance is assessed using the mean and max recall (mRecall and Recallmax) at a
precision range of [0.10, 0.50] with 0.05 interval, and the mean free response operating
characteristic (FROC) at 3, 4, 6, 8 FPs per patient. These operating points were chosen
after confirming with our physician.
Comparison Setups. Using the binary and soft distance-based gating function,
our multi-branch GTVLN detection-by-segmentation method is denoted as multi-
branch BG and multi-branch SG, respectively. We compare against the following
setups: (1) a single 3D UNet [10] trained using RTCT alone or the early fusion
(EF) of multi-modalities (denoted as single-net method); (2) Two separate UNets
trained with the corresponding tumor-proximal and tumor-distal GTVLN samples
and results spatially fused together (our preliminary work [123] denoted as multi-net
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Methods: CT EF mRecall Recallmax mFROC FROC@4 FROC@6
single-net ✓ 0.664 0.762 0.604 0.552 0.675
single-net ✓ 0.731 0.820 0.676 0.667 0.713
multi-net BG [123] ✓ 0.747 0.825 0.695 0.668 0.739
multi-branch BG (Ours) ✓ 0.761 0.845 0.679 0.667 0.716
multi-branch SG (Ours) ✓ 0.782 0.843 0.724 0.729 0.738
MULAN [78] ✓ 0.711 0.758 0.632 0.632 0.642
MULAN [78] ✓ 0.725 0.781 0.708 0.718 0.720
Table 8.1. Quantitative results of our proposed methods with the comparison to other
setups and the previous state-of-the-art.
BG); and (3) MULAN [78], a state-of-the-art (SOTA) general lesion detection method
on DeepLesion [2] that contains more than 10,000 enlarged LNs.
8.3.2 Quantitative Results & Discussion
Our quantitative results and comparisons are given in Table. 8.1. Several observations
can be drawn on addressing the effectiveness of our proposed methods. (1) The
multi-modality input, i.e., early fusion (EF) of RTCT, PET and tumor distance
map, are of great benefits for detecting the GTVLN . There are drastic performance
improvements of absolute 6.7% and 7.2% in mRecall and mFROC when EF is adopted
as compared to using RTCT alone. These results validate that input channels of PET
functional imaging and 3D tumor distance transform map are valuable for identifying
GTVLN . (2) The distance-based gating strategies are evidently effective as the options
of multi-net BG, multi-branch BG and multi-branch SG consistently increase
the performance. For example, the multi-net BG model achieves 74.7% mRecall and
69.5% mFROC, which is a 1.6% and 1.9% improvement against the best single-net
model (where no distance-based stratification is used). The performance further boosts
with the network models of multi-branch BG and multi-branch SG, to the highest
scores of 78.2% mRecall and 72.4% mFROC achieved by the multi-branch SG.
Multi-branch versus Multi-net. Using the distance-based gating strategy, our
proposed multi-branch methods perform considerably better than the multi-net BG
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model. Even our second best model multi-branch BG, the mean and maximal
recalls have been improved by 1.4% (from 74.7% to 76.1%) and 2.0% (from 82.5%
to 84.5%) against the multi-net BG model. When the multi-branch framework is
equipped with the soft-gating, marked improvements of absolute 3.5% and 2.9% in
both mRecall and mFROC are observed as compared against to the multi-net BG
model. This validates the effectiveness of our jointly trained multi-branch framework
design, and our intuition that gradually changing GTVLN weights for the proximal
and distal branches are more natural and effective. As we recall, the multi-net baseline
directly trains two separate 3D UNets [10] targeted to segment each GTVLN subgroup.
Considering the limited GTVLN training data (a few hundreds of patients), it can be
overfitting prone from the split to even smaller patient subgroups.
Table. 8.1 also compares with the SOTA universal lesion detection method, i.e.,
MULAN [78] on DeepLesion [2], [110]. We have retrained the MULAN models using
both CT and EF inputs, but even the best results, i.e., using EF, have a large gap
(72.5% vs. 78.2% mRecall) with our distance-gating networks, which further proves
that the tumor distance transformation cue plays a key role in GTVLN identification.
Fig. 8.3 illustrates the visualization results of our method compared to other
baselines. For the enlarged GTVLN (top row), most methods can detect it correctly.
However, as the size of GTVLN becomes smaller and the contrast is poorer, our
method can still successfully detect them while others struggled.
8.4 Conclusion and Future Works
In this work, we propose an effective distance-based gating approach in a multi-task
deep learning framework to segment GTVLN , emulating the oncologists’ high-level
diagnosis protocols. GTVLN is divided into two subgroups of “tumor-proximal” and
“tumor-distal”, by means of binary or soft distance gating. A novel multi-branch
115
Figure 8.3. Four qualitative examples of the detection results using different methods.
Red color represents the ground-truth GTVLN overlaid on the RTCT images; Green color
indicates the predicted segmentation masks. As shown, for the enlarged GTVLN (top
row), most methods can detect it correctly. However, as GTVLN size becomes smaller
and contrast is poor, our method can successfully detect them while others struggled.
detection-by-segmentation network is trained with each branch specializing on learning
one subgroup features. We evaluate our method on a dataset of 141 esophageal cancer
patients. Our results demonstrate significant performance improvements on the mean
recall from 72.5% to 78.2%, as compared to previous state-of-the-art work. The highest
achieved GTVLN recall of 82.5% at the 20% precision level is clinically relevant and
valuable. Future works can include finding lymph node station firsts and then segment
GTVLN afterwards. Another direction worth considering is to replace the Euclidean
distance map with the geodesic anatomic distance inside the lymphatic system, which
is more realistic.
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Chapter 9
Conclusion and Future Work
In this dissertation, we focus on the topic of improving the state diagnostic medicine by
advancing the volumetric medical image segmentation with state-of-the-art deep learn-
ing techniques. Chapters from Chapter 3 to Chapter 6 are in the scope of segmenting
organs/tumors more accurate while Chapter 7 and Chapter 8 fall into addressing the
detection by segmentation of metastasis-suspicious lymph nodes. In Chapter 3, we
propose the ResDSN network backbone in a general 3D coarse-to-fine framework to
tackle the challenges of limited amount of annotated data and limited computational
resources in volumetric medical image segmentation. The quantitative results show
that the proposed methods can improve the overall segmentation accuracy as well
as the segmentation in the worst case. Chapter 4 and Chapter 5 extend Chapter 3
to segment lethal pancreatic tumors, i.e., PDAC and PNETs, respectively, which
achieve clinically promising sensitivity and specificity. Moving forward, Chapter 6
explores the novel idea of AutoML in the medical imaging field to automatically
search the network architectures tailing for the volumetric medical image segmen-
tation whereas almost all prior works adopt human-designed network backbones.
Moving forward beyond normal organs and tumors segmentation, Chapter 7 is the
first computationally realization of detecting, identifying and characterizing suspicious
cancer metastasized lymph nodes by proposing a 3D distance stratification strategy
to simulate and simplify the high-level reasoning protocols conducted by radiation
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oncologists in a divide-and-conquer manner. Our experiments indicate that the local
textures and global semantically meaningful tagging features can largely improve the
lymph node detection accuracy. Chapter 8 upgrades the distance-based stratification
by a multi-branch detection-by-segmentation network, which further advances the
finding, identifying and segmenting of metastasis-suspicious lymph nodes.
We demonstrate that designing/searching advanced network backbone/architec-
tures and/or migrating rich knowledge from routine works of medical experts into
automatic computer-aided diagnosis solutions can improve both medical diagnosis.
Further works could lie in many directions. First, in a sense that medical image anno-
tation would always be limited in the scope of deep learning, segmentation with scarce
training data (few shot learning), with image-level annotation (weakly supervised learn-
ing), and with a mixture of labelled and unlabelled data (semi-supervised learning) are
important directions. Second, in real applications, computer-aided diagnosis (CAD)
solutions need to be applied to multiple sites, with each site have different protocols,
scanners, population distribution and etc. So domain adaptation [124] would be the
direction to mitigate the data discrepancy across different sites. Third, when CAD
solutions are deployed locally, how to have medical experts in the loop would be an
open question. For example, when medical experts are using the CAD system, how
the feedback of human assessment improves the CAD and how the CAD improves the
human routine works remain challenging. Ideally, the machine intelligence and human
beings iteratively evolve into a win-win situation.
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